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This study examines the influence social support has on delay of treatment among 
African-American lymphoma patients. One hundred nineteen (119) social work 
assessments were collected from medical records utilizing nonprobability sampling. 
Data were extracted from the social work assessments of lymphoma patients considered 
for or having had bone marrow transplantation. The measurement tool was designed 
based on survey information from the Supportive Care Needs Survey, Social Support 
Behaviors Scale and the Social Support Survey Instrument. The findings of the study 
indicated that, overall, social support did not significantly influence delay of treatment. 
However, there were statistically significant relationships among social worker support 
and delay, gender and delay, and type of lymphoma diagnosis and delay for bone marrow 
transplantation. A large percentage of the patient population who may have been 
considered for bone marrow transplantation did not receive social work assessments and 
could have experienced delay associated with limited social support. Further research 
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should be conducted on why this population did not receive social work assessments and 
comparisons should be made to the population that did in order to examine group 
differences. 
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Receiving a diagnosis of cancer can be shocking. Cancer survivors report that 
after having heard the diagnosis, not much else during the consultation is heard. The 
diagnosed person may often enter into a state of denial or begin to have fatalistic 
thoughts. Experiencing stress when given a diagnosis of cancer is a common and 
understandable reaction. Patients immediately begin to process thoughts on what may 
happen to their bodies, how their families will cope with the cancer experience, what the 
future will bring for their children, and harbor fears of dying (Harpham, 2003). 
A psychological, spiritual, and intellectual evolution must occur before 
decision-making about treatment can begin. Some patients may process quicker than 
others and prepare to make treatment decisions promptly. For others, deciding to take 
the next step toward treatment decision-making may be too difficult, which may lead to 
a significant delay in care. 
Delay in care can be costly in many ways and allowing a potentially aggressive 
disease to rapidly progress without treatment may result in undesirable health outcomes. 
The African-American community must be cautioned. Following heart disease, the 
second leading cause of death for African-Americans is cancer. Joiner (2004) examined 
issues concerning African-Americans and cancer mortality and stated that in the early 
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1990’s, 60 percent of Caucasians and only 44 percent of African-Americans met the 
five-year survival rate for cancer. Factors that may jeopardize the health of the 
African-American community and that have been identified as contributors to racial 
disparity in cancer are unequal access to quality medical care, lower socioeconomic 
status, diets that are high in fat and low in fiber, and overexposure to toxic wastes and air 
pollution in urban areas. 
Social work assessments have been collected, for the past ten years, at a local 
hospital, on lymphoma patients whose treatment recommendations included bone 
marrow transplantation. These patients would have been diagnosed with one of three 
particular types of lymphoma usually treated with bone marrow transplantation, namely, 
relapsed follicular non-Hodgkin’s lymphoma, relapsed Hodgkin’s lymphoma, and 
relapsed diffuse large B-cell non-Hodgkin’s lymphoma. There are other types of 
lymphomas that may be treated with bone marrow transplantation and those will be 
included in this investigation. This study will take advantage of a unique opportunity to 
investigate the role social support plays in motivating patients to seek needed treatment 
without unsafe postponements; to explore which of the three types of social support 
- emotional, informational, and instrumental - may play a larger role in encouraging 
compliance; to address the issue of disparity in cancer incidence and mortality of the 
African-American community; and to add to the knowledge of bone marrow 
transplantation patients and their social support needs. 
Social workers, who practice in the field of oncology, are dedicated to providing 
supportive care to cancer patients with a variety of needs. Though research on cancer has 
been conducted for decades, and the challenges of understanding and treating cancer are 
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still critical, cancer statistics are daunting for the African-American community, as well 
as statistics on other serious chronic illnesses. Health disparity research is prevalent and 
efforts to address and resolve urgent health issues of late-stage diagnoses and medical 
noncompliance continue. Social workers are charged with providing multifaceted 
services to their patients on the clinical, administrative, educational, and advocacy/liaison 
levels. Social workers at many hospitals pay especially close attention to bone marrow 
transplantation patients because of the additional care required in treatment that may 
result in severe complications, and they aim to facilitate healing environments for cancer 
patients, through the identification and attainment of various types of social support 
already confirmed, by study findings, to be beneficial to health outcomes. 
Limited research is available on African-Americans diagnosed with lymphoma 
and considered for bone marrow transplantation. This study aims to provide further 
understanding of what the particular needs are of African-American bone marrow 
transplantation patients in relationship to social support. In addition, the study will 
explore the support needs of bone marrow transplantation candidates and/or recipients. 
Determining effective social work interventions to address current challenges and 
supportive needs of this population may be extended to other identified urgent care needs 
of the African-American community. 
During 1996 and 2000, the cancer incidence rates or number of new cases 
for African-Americans were the highest among the racial groups, with 696.8 
African- American males per 100,000 cases per year and 406.3 African-American 
females per 100,000 cases per year. Cancer death rates are also the highest among the 
African- American community, with 356.2 males per 100,000 cases per year and 198.6 
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females per 100,000 cases per year. Differences in exposure, access to screening, and 
quality care are factors that may contribute to incidence and mortality variants (National 
Cancer Institute, 2005). 
In 2005, approximately 1.4 million new cancer cases and 570,000 deaths due to 
cancer were expected in the United States. African-American men and women have 40 
percent and 20 percent higher death rates from all cancers than Caucasian men and 
women. African-American women have lower incidence rates while African-American 
men have a 24 percent higher incidence than Caucasians. Minority populations are more 
likely to be diagnosed with advanced stage disease than are Caucasians (A Cancer 
Journal for Clinicians, 2005). 
When African-Americans receive the diagnosis of cancer, they are more likely to 
present with cancer at a distant stage rather than localized stage. Cancer at the more 
localized stage is easier to treat. For almost every type of cancer, five year survival is 
lower among African-Americans than in Caucasians. Joiner (2004) reported that 
African-Americans experience similar disease outcomes as Caucasians when they have 
equal access to quality cancer treatment. 
Obtaining quality health care can be a challenging endeavor for 
African-Americans. In particular, for stem cell transplantation, physicians are the major 
decision-makers on which patients make good transplantation candidates. Selection 
criteria for all transplantations and the availability of matching donors for allogeneic 
transplantation can compromise health outcomes for African-Americans, if they are not 
deemed good candidates. Not having adequate social support, or possessing a history of 
smoking or substance abuse are other possible criteria that can deselect a patient with any 
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serious chronic illness from receiving technologically advanced or special medical 
treatments associated with high risks for complications. Freeman (2006) is concerned 
that kidney transplants and surgery for early-stage cancer of the lungs, colon, and breast 
are not appropriately recommended or provided to African-Americans as readily as these 
treatments are accessible to Caucasians. 
African-Americans make up 12 percent of the U.S. population but the incidence 
and mortality rates for many chronic illnesses among African-Americans are alarmingly 
disproportionate. Technology and research have made significant advancements in 
medicine but these potential technological benefits have not adequately reached the 
African-American community. 
African-Americans still rely on the ancient African teaching of “God force is 
our life force” (Chissell, 1993, p. xxvi). Health care professionals must be conscious 
of these beliefs and values and charged with providing culturally sensitive care to 
African-American patients. The push from major national organizations for researchers 
to conduct health disparity studies indicates that many of the already identified barriers to 
treatment remain unaddressed and knowledge on how to remove the barriers must be 
obtained. 
African-Americans diagnosed with cancer may delay seeking recommended 
treatment that, unfortunately, significantly impacts quality of life, but offers a good 
prognosis. Having little trust in receiving appropriate medical care and fearing the cost 
of treatment for serious illnesses may cause delay or noncompliance. The reasons for 
their delay may or may not be rational but surely cannot be ignored. 
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Having access to supportive social interactions facilitates emotional stability and 
encouragement to pursue necessary medical care. Cancer patients possessing positive 
social support systems are motivated to comply with treatment recommendations. Health 
care professionals are becoming more aware of the study results that advocate and 
support the beneficial influence of positive social support systems, formal and informal, 
on patient compliance. Research findings have indicated that social support improves 
overall well-being. These studies, however, generally utilized middle-class, Caucasian 
people for research subjects. Not much is known about African-American social support 
experiences. Research has traditionally been designed and conducted with the 
assumptions that most people share similar beliefs and values in the United States 
(Hamilton, 2004). 
Statement of the Problem 
African-American men and women who have been diagnosed with cancer are 
presenting for detection and treatment at later stages of the disease, which cancer 
statistics indicate, significantly affects disease outcome. The identification of social 
factors that influence the timely initiation of recommended treatment will be examined. 
Purpose of the Study 
The purpose of the study is to examine the influence social support, specifically 
emotional, instrumental, and informational, has on delay in the treatment of lymphoma 
patients considered for bone marrow transplantation. Data extracted from the medical 
records of African-American patients who have been diagnosed with relapsed 
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lymphomas and considered for bone marrow or stem cell transplantation at metropolitan 
Atlanta, Georgia hospitals will be used in this study. 
Research Question 
The research question for the study is as follows: 
Does having access to emotional, informational, and/or instrumental 
support decrease the amount of time between receiving a lymphoma 
diagnosis and receiving initial recommended treatment? 
Hypothesis 
The null hypothesis for the study is as follows: 
There is no statistically significant relationship between emotional, 
informational, and/or instrumental support and the amount of time 
between receiving a lymphoma diagnosis and receiving initial 
recommended treatment. 
Significance of the Study 
This study purports to shed some light on the problems related to disease outcome 
of African-American patients diagnosed with cancer or other serious chronic illnesses 
and investigate the influence social support has on health outcome. 
The perplexing issue is that while diagnosing and recommending treatment for 
serious chronic illnesses among people from diverse cultures, health care teams must be 
aware of the many potential treatment barriers in order to make medical services as 
accessible as possible. 
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This may be difficult to accomplish without the expertise of social workers. 
Social work in health care must be recognized as providing primary and holistic services 
that transcend settings, supporting diversity and helping to strengthen the dyad of 
individual and community well-being (Lowe, 1997). 
CHAPTER II 
REVIEW OF LITERATURE 
This chapter is a review of the current literature related to this study. The intent is 
to develop a better understanding of how to promote more timely access to cancer care 
among African-Americans. This chapter is divided into seven sections. The sections are 
an overview of cancer; national and Georgia trends for lymphoma; clinical description of 
lymphoma, including description of relapsed Hodgkin’s, diffuse large B-cell, and 
follicular lymphomas; treatment delay; social support; social work and oncology; and 
theoretical framework. 
Cancer 
Prior steps to substantially reduce the burden of cancer among African-Americans 
have been insufficient. There are over 35 million African-Americans, descendants of 
persons from Africa who were involuntarily relocated to the United States and the 
Caribbean, during the African diaspora of the 17th to 19th centuries. If diagnosed with 
cancer, members of this population can expect to have poorer 5-year survival than other 
Americans (Underwood, 2003). 
In a health behaviors survey of 1,253 African-Americans in several Alabama 
churches, the majority of respondents indicated they believe in destiny. With serious 
chronic health issues devastating the African-American community, the study findings 
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addressed the importance of developing health education and motivational interventions 
specifically for African-Americans. African-American health behaviors should be 
further researched in order to identify more appropriate and effective interventions 
(Green, et al., 2003). 
In a report by the Chairman on the National Cancer Institute’s President’s Cancer 
Panel, a moral doctrine was advanced by patients and professionals in attendance at a 
series of panel sessions held in 2000 and 2001 : no person in America with cancer should 
go untreated, experience insurance-related diagnosis or treatment delays that jeopardize 
survival, or be bankrupted by a cancer diagnosis (NCI, 2000-2001, p. i ). 
The American Cancer Society (ACS) is a voluntary health organization with 
national and international involvement that focuses on the prevention of cancer through 
research, education, advocacy, and patient services. The ACS celebrates more than two 
million volunteers, is recognized as the largest source of private, nonprofit cancer 
research funds (several billions) in the United States; and its advocacy efforts include the 
improvement of access to health care services for all Americans, as well as, protecting 
the rights of cancer survivors (American Cancer Society, 2005). 
In 1995, the ACS established the Behavioral Research Center (BRC) with the aim 
of expanding research and focusing on supporting oncological, psychosocial and 
behavioral research. The BRC investigates the cancer experience from the aspects of 
prevention, screening, treatment, survivorship, and end-of-life concerns, paying special 
attention to those who may experience disparities. The BRC has three basic functions: 
1. To conduct original psychosocial and behavioral research on cancer; 
2. To provide consultation to other parts of the ACS; and 
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3. To carry out research that will provide the transfer of behavioral, 
psychological, and policy-knowledge and theory to improve cancer 
control practices (ACS, 2004, Research Program & Funding page). 
Several BRC research projects exists that all appear to have similar goals of 
describing unmet needs of cancer survivors and focusing on psychosocial adjustment, 
quality of life, and survivorship concerns. These major American institutions are 
recognizing, through the initiatives they have set forth, serious issues of access to quality 
care among certain groups in this nation (ACS, 2005). 
National Trends for Lymphoma 
In the United States, lymphoma represents five percent of all cancers. An 
estimated $5 billion per year is spent on treatment and close to $120 million per year 
is spent on lymphoma research. The two types of lymphoma are referred to as 
non-Hodgkin’s (NHL) and Hodgkin’s lymphoma (HL). Annually, approximately 8,000 
new cases of HL will occur and 1,400 deaths are predicted. Overall mortality has more 
rapidly decreased for HL than for other cancers, due to radiation and chemotherapy 
treatment effectiveness. The disease is more common in men than women and, in people 
ages 15 through 34 and older than 60 (NCI, 2005). 
In the United States, the incidence rate from 1995-1999 for HL among 
African- American men was 2.7 per 100,000 compared to 3.4 per 100,000 for Caucasian 
men. For African-American women, the incidence rate was 13.3 per 100,000 compared 
to 19.3 per 100,000 for Caucasian women. During the same time span, the mortality 
rates were 8.5 and 5.1 for African-American men and women compared toi 1.8 and 7.9 
12 
for Caucasian men and women. Much closer attention should be given to the presence of 
lymphoma in the African-American community. Comparison rates are alarming for the 
African-American community, which is just 12 percent of the total United States 
population (NCI, 2005). 
The incidence for NHL has been rapidly increasing, approximately 73 percent 
between 1973 and 1991. The current U. S. rate is 15.1 cases per 100,000 people (Kallab, 
2002). 
This rate has risen per 100,000 persons from 11.1 in 1975 to 19.0 in 2000. Even 
considering statistical findings that HIV infection increases the risk of NHL, this does not 
adequately explain the overall increase of incidence rates of NHL. During the past 
decades, this increase for NHL exceeds the increased incidence for all other types of 
cancer except melanoma and lung cancer. While the etiology for melanoma and lung 
cancer is known, the etiology for NHL is not (Groves, et ah, 2000). 
It was estimated that 53,400 new cases of non-Hodgkin’s lymphoma (NHL) were 
diagnosed and 23,400 patients would die from NHL in 2003. The etiology of NHL has 
been associated with the use of hair-coloring products, pesticides, cigarette smoking, 
alcohol consumption, and blood transfusion. Further research is needed to confirm these 
associations (Zhang, 2004). 
Exposure to hazardous occupational conditions among African-American men 
has been found to be disproportionate and that these men may have been exposed to 
chromium, an established human carcinogen that has been linked with close to a 
four-fold increase in the risk of NHL. This study on race-specific occupational risk 
factors, which utilized questionnaires administered by professional interviewers, included 
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959 subjects who worked in jobs with high risk exposure to chromium (chromate 
industry), wood dust (saw mills), and pesticides. African-American men also had 
increased risk for HL due to wood dust exposure but there was not the same risk for 
Caucasian men (Briggs, 2003). 
African-American to Caucasian NHL incidence ratios for 1995 to 1999 were 19.9 
per 100,000 to 24.5 for males and 11.2 per 100,000 to 16.5 for females. The mortality 
ratios for African-American to Caucasian were 7.8 per 100,000 to 11.2 for males and 4.7 
per 100,000 to 7.5 for females (Ghafoor, et al., 2006). 
The five-year relative survival rates for NHL from 1995 to 2000, were 51 
percent survival for African-Americans and 60 percent survival for Caucasians. 
African-Americans have less likelihood of surviving five years after diagnosis than 
Caucasians (ACS, 2005). 
Georgia Trends for Lymphoma 
In the State Cancer Profiles for Georgia, the five year rate changes in mortality 
for African-Americans with NHL (1998-2002) were rising at 2.8 compared to the falling 
rates for breast, prostate, and lung cancer. In Atlanta, Georgia, the five year rate changes 
in African-American mortality for the same years were rising at 5.7. There were no local 
incidence and mortality statistics available for follicular, Hodgkin’s, and diffuse large 
B-cell lymphomas (State Cancer Profiles, 2006). 
Clinical Features of Lymphoma 
There are two groups of cancers (HL and NHL) that occur in the lymphatic 
system. This system, which protects the body from infection, is made of vessels that 
14 
branch into the tissues of the body. The vessels contain a watery fluid consisting of 
lymph and lymphocytes, which are infection-fighting cells. Lymph nodes are small 
organs that are located throughout the lymphatic system and they can be found in the 
groin, chest, neck, underarms, and abdomen (NCI, 2005). 
For both types of lymphoma, cells in the lymphatic system divide too quickly and 
grow without appropriate control. The lymphatic tissue is located throughout the body, 
which allows for HL to present anywhere within the body. This disease is known to 
systematically spread, moving from one group of lymph nodes to another. HL is 
responsible for less than 1 percent of all cancer cases in the United States. There are 
different types of HL. The etiology is unknown and health care professionals find it 
difficult to predict who will or will not develop the disease. Clinicians and researchers 
do know that the disease is not contagious nor is it caused by shock or trauma. HL can 
be cured and/or controlled for many years (NCI, 2005). 
NHL is the sixth most common cancer. NHL starts in the lymphatic system and 
spreads to other organs. The prognosis depends on the type of NHL, stage of the disease, 
and treatment. There are many different types of NHLs, which are categorized by two 
prognoses. If the NHL is indolent, then the prognosis is good and the patient has a 
survival rate of approximately ten years. If the NHL is aggressive, which is occurring 
more frequently in HIV-positive patients, the survival rate is approximately five years. 
Thirty-six percent of patients with aggressive NHL can expect to be cured (NCI, 2005). 
In a study examining the impact of HIV infection on NHL, African-Americans 
with HIV/AIDS were found to have lower incidence rate of NHL but with the same 
disease combination among this population, the death rates have significantly increased. 
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Particular focus on HIV/AIDS and the African-American community is becoming more 
important. Diffuse large B-cell lymphoma is another type of lymphoma seen in people 
with HIV/AIDS. Special effort should be taken to bring awareness about the 
complications of these diseases (Hooper, et al., 2001). 
A fine needle aspiration of fluid from the cancer site and/or a biopsy which is the 
removal of a sample of tissue followed by microscopic examination to see whether 
cancer cells are present, are utilized to help ascertain a diagnosis. Blood tests, scans, 
x-rays, and bone marrow samples are also collected (NCI, 2005). 
The process of staging the disease is the determination of the extent to which the 
cancer has spread from its original site to other parts of the body. If there are additional 
medical problems caused by the cancer, further assessment will also occur at this time. 
Information is provided to the patient about how quickly treatment should start, and best 
recommendations on the treatment choices are provided. It is important to note that 
staging procedures may cause treatment delay (Harpham, 2003). 
The stage of lymphoma indicates the number of groups of affected lymph nodes, 
where they are located in the body, and the identification of other organs that may be 
affected such as the bone marrow: 
Stage 1 - The lymphoma is in one group of lymph nodes in one specific area of 
the body 
Stage 2 - The lymphoma is in more than one group of lymph nodes, but all the 
affected nodes are contained within either the area above the diaphragm and 
below the diaphragm of the body 
Stage 3 - The lymphoma is in lymph nodes above and below the diaphragm 
Stage 4 - The lymphoma has spread beyond lymph nodes to other parts of the 
body (CancerBACUP, 2005). 
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Treatment 
There are several methods of treatment for cancer for which the National 
Comprehensive Cancer Network (NCCN) has standardized. Surgery, which is the 
removal of a tumor by excision, is a common treatment method. Medicines such as 
anticancer drugs, hormone-blocking/supplementing drugs, and drugs that support the 
immune system are utilized. Steroids are often used to reduce feelings of sickness. 
There are a number of chemotherapeutic drugs that are often used in combination with 
supportive treatments. Biological therapy such as immunotherapy aims to strengthen the 
immune system to help fight cancer. Biological therapy employs such agents as 
interferons, interleukins, colony stimulating factors, tumor necrosis factors and 
monoclonal antibodies. Monoclonal antibody therapy is another treatment that uses the 
drug known as rituximab. This treatment is usually given with chemotherapy as part of a 
common regimen called CHOP-R, which uses the following combination of drugs: 
doxorubicin, cyclophosomide, vincristine, prednisolone with rituximab. Treatment 
with high-energy radiation is an important cancer therapy. Radiotherapy is the use of 
high-energy rays to destroy cancer cells while doing as little harm as possible to the 
healthy cells. It may also be given in addition to chemotherapy. A combination of all 
treatment methods is utilized depending on the diagnosis and staging (NCCN, 2005). 
Bone marrow transplantation and stem cell transplantation are two important 
treatment methods considered for the cancers discussed in this study. Bone marrow is 
the soft, spongy tissue found in the center of large bones that produces white blood cells, 
red blood cells, and platelets. Bone marrow transplantation is a treatment in which bone 
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marrow that has been affected by a disease or by treatment for a disease is replaced with 
healthy bone marrow (NCI, 2005). 
Out of thousands of people searching for a bone marrow transplantation match, a 
growing percentage of those are African-Americans, for whom finding a match can be 
extremely difficult (Reyes, 2005). 
Laver et al. (2000) researched bone marrow donation and assessment of barriers 
among African-Americans. Surveys were administered to 589 participants to assess their 
attitudes towards donation. The study results showed that, in searching the National 
Marrow Donor Program registry, Caucasians have about an 80 percent chance of 
receiving an unrelated donor while African-Americans have less than a 30 percent 
chance. An awareness that transplantation saves lives and how donations can be made 
must be effectively promoted throughout the community. 
Stem cell transplantations facilitate the use of more aggressive anticancer 
therapies. Blood is drawn from a vein in the patient’s arm by which the patient’s own 
stem cells are collected and utilized to rescue the bone marrow destroyed by 
chemotherapy and/or radiation therapy. Autologous and allogeneic stem cell 
transplantations are two types of stem cell treatments. Allogeneic transplantations rely 
on stem cell donors. In autologous transplantation, the patient’s own stem cells are used 
for anticancer treatment (Harpham, 2003). 
Transplant centers assist with the documentation needed to authorize coverage of 
transplantation, which can costs well over $100,000. Working with insurance providers 
can be difficult. Financial support for transplants can be provided with the assistance of 
special organizations and fundraisers (Stewart, 2000). 
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Stockerl-Goldstein et al. (2000) reported that the total cost of posttransplant care 
ranged from $80,000 to over $140,000. When treatment is not successful, 
transplantation-related deaths can be attributed to the following conditions: multiorgan 
failure, interstitial pneumonitis, hepatic failure, inadequate pulmonary function, multiple 
prior chemotherapy regimens, prior chest irradiation, and gastrointestinal bleeding. 
Participation in a clinical trial is a viable treatment choice for cancer patients. A 
clinical trial is a form of research involving cancer patients that is intended to test new 
drugs and to uncover more efficient, beneficial treatment methods. There are situations 
where standard cancer therapy is not reliable and clinical trials may offer better treatment 
and follow-up opportunities as well as offering treatment at no costs to the patient (NCI, 
2005). 
Most treatment regimens are aimed at killing the cancer cells or tumors that 
inhabit the patient’s body, but these therapies can exact an unwelcome impact on the 
body’s normal organs unrelated to the cancer. The negative consequences of treatment 
are referred to as side effects or complications to treatment. Many types of complications 
can occur with some of the more common side effects being the following: anemia, 
fatigue, infection, fever, mouth sores, nausea/vomiting, hair loss, pain, depression, and 
death. Side effects can impact overall treatment outcome by interfering with therapeutic 
regimens (CancerConsultants.com, 2006). 
Harpham (2003), a physician and cancer survivor, explained how a person may be 
considered cured of cancer: The most desirable cured state would be no detectable sign 
of cancer and life expectancy would remain the same as before the cancer originated. A 
one year remission may be considered a cure and, after a five year remission, the 
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likelihood of a cancer recurrence is low. Unfortunately, there is a greater chance of 
developing the same type of cancer with some lymphomas that are considered incurable. 
Not only will patients require information on symptoms, diagnoses, side effects, 
coping strategies, and cures, a prognosis is also expected. A prognosis is a prediction of 
the recovery and outcome of a serious disease state (NCI, 2005). 
Relapsed Hodgkin’s Lymphoma 
Relapsed Hodgkin’s lymphoma (relapsed HL) is the recurrence of the disease in 
prior and/or new locations in the body. Relapse may occur within the first 2-3 years after 
the original treatment. The major risk factor for relapsed HL is resistance to 
conventional treatment. Chemotherapy, radiation, bone marrow and stem cell 
transplantation are treatments used for relapsed HL. When treatments must be repeated 
due to relapse, subsequent rounds of therapy are determined by where in the body the 
disease has returned, stage of relapsed HL, and prior treatment approaches (University of 
Maryland Medical Center, 2005). 
Relapsed HL has a cure rate that ranges from 10 to 50%. When relapse occurs, 
there is a decrease in the chance for long-term survival. Cure rates decrease if relapse 
occurs within the first year after initial treatment. The later the relapse after initial 
treatment, the better the cure rate will be (Merck, 2006). 
Follow up examinations may occur every two to three months for two years, 
every four to six months for the next three years, then annually after five years. Patients 
relapsing within one year may benefit from high-dose therapy until maximum response is 
attained (emedicine.com, 2002 ). 
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Relapsed Diffuse Large B-Cell Lymphoma 
Diffuse large B-cell lymphoma (DLBL) is the most common lymphoma and is a 
rapidly-growing, aggressive NHL. This cancer type accounts for more than 30 percent of 
all lymphomas in the United States and affects approximately five individuals out of 
100,000 each year. DLBL is a little more common in men than women and Caucasians 
than other races/ethnicities. It can occur within an age range of 10-88 years. The median 
age range at diagnosis is from 57-64 years and found most often in patients in their 70s. 
Mortality rates are significantly increasing in each race/sex group, with these increasing 
rates highest in areas where either HIV is epidemic or patients experience posttransplant 
diseases. The projected 5-year survival rates appear to be higher for Caucasians than for 
African-Americans (Kallab, 2002). 
DLBL is a high-grade (rapid growing) lymphoma, which needs prompt treatment. 
DLBL can be fatal but with the appropriate treatment, the cure rate is approximately 50 
percent. DLBL is a cancer which affects the B-lymphocytes. B-cells and T-cells are two 
main types of lymphocytes. Lymphocytes originate in the bone marrow or lymph nodes, 
where the B-cells mature and may develop abnormally. The T-cells leave before 
maturation and finish the development process in the thymus gland (Lymphoma 
Information Network, 2005). 
DLBL can arise from other kinds of lymphoma or emerge due to genetics. 
Symptoms of DLBL are referred to as B symptoms, with one of the first being a painless 
swelling in the neck, groin, or armpit. The swelling is caused by enlarged lymph nodes. 
The lymphoma can spread throughout various organs of the body. Tiredness, appetite 
loss, and night sweats are additional symptoms that may be experienced. Chemotherapy 
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is the main treatment for DLBL. The stage of lymphoma, age and general health of the 
patient are considered when determining the type of chemotherapy to use. Outpatient 
treatment for 4-6 months is standard. High-dose chemotherapy with bone marrow or 
stem cell infusions has been effective in the treatment of DLBL. Radiation therapy can 
also be included. Side effects can be severe and the cancer specialists are very careful 
about prescribing this type of treatment to patients over the age of 45. However, 
especially fit patients, up to age 65, may be able to handle high-dose treatment 
(CancerBACUP, 2005). 
Between 26 percent and 73 percent of patients with DLBL will be disease free for 
5 years after diagnosis. If the patient is disease free for four or more years, the disease 
will seldom return (UpToDate Patient Information, 2005). 
Relapsed Follicular Non-Hodgkin’s Lymphoma 
Follicular lymphoma (FL) is one of the more common NHLs in the United States. 
Patients typically present with the disease in multiple parts of the body. FL is a B-cell 
lymphoma. The average age at diagnosis is 60 years old and the disease has progressed 
to the later stages. Risk factors for FL may be environmental, including exposure to 
chemicals, such as pesticides and hair dyes (Lymphoma Information Network, 2005). 
Adult patients with early stage disease may be treated with local radiation. When 
treatment is necessary, chemotherapy, combined chemotherapy, whole body irradiation, 
or bone marrow transplantation may be recommended. For all other stages, close follow 
up is needed. The patient is followed for the development of systemic symptoms such as 
fever or weight loss. The overall survival rate of patients is 72-77% at five years. The 
median survival time is 10 years. These lymphomas have a better prognosis than higher 
grade lymphomas (Lymphoma Information Network, 2005). 
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Treatment Delay 
After a person receives a diagnosis of cancer, and has begun to process how the 
diagnosis and treatment will impact quality of life in very specific ways, conscious or 
subconscious treatment decision-making begins. Treatment begins promptly for some 
patients, while others may experience delay. Reportedly, 30 to 50 percent of cancer 
patients will not begin treatment, specifically, chemotherapy (Hudson, 1998). 
Timely diagnosis and treatment at an early stage of disease is significant when 
pursuing cancer cures. Delay in seeking cancer treatment is closely related to advanced 
stage of disease at diagnosis (Bradley, 1998). 
Rolland (1994) provides a time line that groups the phases of illness, beginning 
with the crisis phase of prediagnosis or symptomatic period and diagnosis, through the 
chronic phase of illness and ending with the terminal phase of death. He addresses the 
important psychosocial factors associated with the chronology of serious diseases so that 
the patient, family, and clinician can be prepared for the critical tasks necessary for each 
phase. One critical task occurs during the span between diagnosis and initial treatment, 
which is an extremely stressful period. The decision has to be made on whether or not 
treatment will be sought. 
In a review of treatment delay definitions, total delay occurs from beginning of 
symptoms to the start of professionally recommended care. In 6 to 16 percent of research 
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cases, delay from physician visit to first treatment appointment typically exceeded three 
months (Richards, et ah, 1999). 
After diagnosis, staging, and receipt of the treatment recommendation, increased 
compliance can result if physicians provide information on how much time a patient may 
take before starting the first treatment. The aim is to allow the patient adequate time to 
process information about the diagnosis and treatment, without increasing cancer risk 
(Harpham, 2003). 
A systematic review of 87 worldwide studies was conducted on influence of delay 
on survival in breast cancer. Two hypotheses were tested: 1 ) longer delays are linked 
with lower survival; and 2) longer delays are linked with more advanced stage. The most 
frequently reported delay times were from 3 to 6 months and the most frequently 
reported outcome measure was a 5 year survival period. Delay and tumor size was 
statistically significant. According to the investigators, lower survival is linked to delays 
of three to six months. The results supported the hypotheses (Richards, 1999). 
Richards et al. (1999) conducted another study with approximately three thousand 
breast cancer patients who answered questions in an examination on the impact of delay 
on survival. Patients who presented with breast cancer in a London hospital from 1975 to 
1990, were followed-up for the study. The two delay intervals researched were first 
between symptom onset and first visit to the hospital, and the second interval between 
symptom onset and first treatment which was considered total delay. Delay intervals 
used in the study were less than three months, three to six months, and more than six 
months. The results indicated that survival was worse among women with longer delays 
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and that, specifically, delays of 12 to 26 weeks were strongly associated with poor 
survival rates and more advanced stage of illness. 
In a questionnaire-based study investigating the differences in delay and 
psychological distress among 252 male and female cancer patients in Norway, the 
diagnostic delay was more distressing for females than males. The three different 
periods of delay studied were before consulting the general practitioner to report 
symptoms, before attending the local hospital in response to the general practitioner’s 
referral, and before attendance at the oncological unit. The delay before consulting the 
general practitioner was from one to four weeks, with women experiencing a shorter 
delay than men among, in particular, the non-Hodgkin’s lymphoma patients. Delay 
before the referral response was from one week to three months and the delay was shorter 
among the higher educated and those less than 50 years of age. Patients were admitted to 
the oncology unit within the first month. The delay time intervals used for analysis in 
this study were less than one week, from one to four weeks, from one to three months 
and more than three months (Risberg, et al., 1996). 
Saavedra (2004) examined the health behavior trends (delays and refusals in 
treatment) of American Indian, Hispanic, and non-Hispanic white breast cancer patients 
residing in New Mexico. A retrospective study was conducted examining the medical 
charts of 434 patients. A qualitative component was included in the study. The results 
indicated the delays experienced in diagnosis, treatment and/or refusal of treatment was 
11.7 percent. More delays / refusals were experienced by American Indian women than 
the other ethnicities represented in the study. 
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Examining noncompliance studies may provide indicators of why treatment delay 
occurs. Missing just one appointment can be considered noncompliant. Results from 
health behavior studies revealed various reasons for noncompliance: not remembering 
appointment dates and times, having transportation problems, and experiencing anxiety 
about the diagnosis, treatment, and medical care costs (Hudson, 1998). 
Oncologists were surveyed about patient noncompliance and half of these 
clinicians admitted experiencing difficulties with patients failing to make their initial 
appointments. The researcher believes the number of oncologists with compliance issues 
is higher than what was reported and surmised there were attempts to avoid negative 
reflection on the clinician (Hudson, 1998). 
In a qualitative study investigating treatment plan decisions among cancer 
patients, 10 patients, aged 61 to 76 were interviewed. Complying with participation and 
complying without participation were factors examined: 
1. Complying with participation was characterized by feelings of 
self-confidence and self-competence and by open dialogues between the 
participants, significant others and the physician. 
2. Complying without participation was characterized by participants’ 
feelings of uncertainty and distress, and of being rushed into submitting to 
decisions without having time to reflect on the information provided or the 
opportunity to influence the treatment and care process. 
3. There is an implicit imbalance of power in the relationship between 
patients and health care professionals. 
4. Each person is profoundly affected by all aspects of a relationship in 
which the other party has superior communication skills that are used to 
influence him or her to accept certain conditions, especially in 
circumstances where he or she has received a potentially life-threatening 
diagnosis, such as cancer (Ramfelt and Lutzen, 2005, p. 143-144). 
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DiMatteo (1994) explains that approximately 38 percent of patients neglect short 
term treatment and approximately 43 percent are noncompliant with long term treatment. 
He is convinced that if the patients agree with the treatment recommendations and 
possess the mandatory resources, then compliance occurs and that it is the provider’s 
responsibility to educate the patient and instill belief that the treatment recommendation 
is correct. The physician must effectively communicate with and understand the patient 
well enough to make the treatment alliance a successful one. Patient concerns also 
include the amount of time away from work, childcare responsibilities, incorporating 
pill-taking, and other treatment procedures into a daily schedule. 
If there is any kind of substantive travel involved in the pursuit of treatment, and 
limited support is available, traveling can be a barrier to treatment, causing delay. 
Research was conducted examining 118 patients’ perspectives on traveling for cancer 
treatment. The analysis uncovered the disagreeable experience of waiting, the idea of 
traveling as being stressful and the actual traveling and being away from home as tiring 
and presenting many conflicts (Fitch, et al., 2003). 
Medical treatment is often delayed because of costs. Depending on the severity 
of the illness, cost of cancer treatment can be shockingly exorbitant for patients who may 
be underinsured, uninsured, or even insured. Medical care affordability is problematic 
and Greenwald (1986) made the following observations about managed care, medical 
costs, and care delay: 
• Those treated in the HMO or making copayments encountered 
significantly longer time lags between diagnosis and the commencement 
of treatment than those receiving fully insured fee-for-service care; 
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• Predicting time from diagnosis to treatment, includes positive and 
statistically significant coefficients on the variables of HMO membership 
and copayment; 
• These significant coefficients indicate that both those who belonged to the 
HMO and those who copaid waited longer between receiving diagnosis 
and beginning actual treatment than those in fully insured, fee-for-service 
situations (Greenwald, 1986, p. 651). 
Misdiagnosis caused delay of 12 to 18 months in the diagnosis of 
melanomas, which was reported in a study on professional delay in the diagnosis of 83 
patients with acral melanoma. Twenty-seven melanomas were clinically misdiagnosed 
by physicians and the delay in diagnosis was associated with advanced stage of disease 
and lower survival rate (Metzger, et al., 1998). 
The dynamics of physician delay have not been well investigated. In a study on 
diagnostic delay in breast cancer, unimpressive physical findings was reported as a 
common cause of physician delay. Researchers found that the results of physician delay 
in terms of overall outcome were not statistically significant. Eight percent of the 606 
subjects who experienced physician delay of greater than three months had larger cancers 
but did not exhibit significant differences in pathology, treatment, or outcome (Tarttler, 
et al„ 1999). 
Goodson and Moore (2002) researched the causes of physician delay by 
examining records in a practice that regularly utilizes screening mammography. The 
cases of 435 patients were investigated. Forty-four patients received incorrect diagnoses 
because of misread mammograms and pathologic findings, poorly performed fine-needle 
aspirations that missed the cancer, and the major cause of physician delay in breast 
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cancer diagnosis was, reportedly, providing benign diagnosis without biopsy when there 
actually was malignancy. 
Sandovsky (2002) received similar results in his study on reducing physician 
delay in breast cancer diagnosis. He reported that misreading mammograms as benign 
was the most prevalent cause of physician delay and the investigator suggested physician 
use of practice guidelines to avoid this kind of delay. 
Data collected and analyzed on over 2000 patients with breast and colorectal 
cancer in Germany indicated breast cancer patients who lived further away from cancer 
centers received faster treatment at hospitals. There was no difference in treatment for 
colorectal cancer patients living in rural and urban areas. There was variation in delay 
between general practices. Practices with more female general practitioners were 
associated with less delay (Robertson, et al., 2004). 
In a study on patient and provider characteristics, the investigators reported, 
“There is considerable variation in treatment and outcome not explained by traditional 
prognostic factors” (Hodgson, et ah, 2001, p. 501). Identified variations in this study 
were: 1) inadequate physician knowledge of practice guidelines; 2) treatment 
decisions based on unmeasured clinical factors; and 3) patient preferences. 
The Selker et al. (1989) Delay Tool was utilized to analyze 201 medical records 
and identify unnecessary administrative hospital delays. There are nine categories in the 
Delay Tool: test scheduling, test results, surgery, consultation, patient, physician, 
education, discharge, and facility/bed unavailability. The significant findings provided 
the following recommendations: “The micro recommendations addressed specific issues 
related to the unavailability of outside resources, discharge planning and physician 
29 
involvement and the macro recommendations focused on the crisis in long-term care, 
financing of long-term care, and the impact of the nursing shortage” (Anders, 1990, 
abstract). 
A review on equitable access to cancer services was conducted and identified 
patient, provider, and system barriers to services. Patient barriers are associated with old 
age, ethnicity, and low socioeconomic class. The review of system barriers identified 
managed care organizations as providing high levels of screening to healthy people but 
more research is required to examine interventions with diverse populations. The 
findings indicated “providers are often ill-prepared to communicate the complexities of 
cancer care to their diverse patient populations” (Mandelblatt, et al., 2000, p. 2378). 
Miller and Bovbjerg (2002) examined patient safety in large, capitated medical 
groups. Shortcomings in diagnosis, abnormal tests follow-up, scope of practice and 
referral patterns, and continuity of care were targeted patient safety problems. The 
researchers reported that medical care could be safer. Their qualitative study included 
background information obtained from interviews with insurance company managers, 
malpractice law experts, patient safety associations and consulting firms. Data on types 
of legal claims from 1985 to 1999 was provided by the Physician Insurance Association 
of America (PIAA). Delay in diagnosis and misdiagnosis were considered the most 
common source of avoidable injury. Unpublished PIAA data that was obtained revealed 
close to two-thirds of categorized physician errors: failure to do something or delay in 
doing something. The specific categories are identified: 1) errors in diagnosis (40.8 
percent); 2) failure to supervise or monitor cases (8.8 percent); 3) activities not 
performed (4.1 percent); 4) failure to recognize a complication of treatment (4 percent); 
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5) failure or delay in referral to a specialist (3.8 percent); and 6) delay in performance 
(2.6 percent). 
Miller and Bovbjerb (2002) identified organizations’ present methods of changing 
processes to prevent injuries. Five categories were provided: 1) identify events/ 
problems; 2) analyze and track incidents; 3) decide on new standards and how to 
intervene to change systems; 4) intervene to support new standards; and 5) monitor 
performance. Internal and external factors to promote patient safety were identified. 
External factors are litigation, accreditation and public regulation, competition, payment 
method, professionalism, and consumerism. The internal factors are size of group, 
physician leadership and governance structures, past successful process change and 
intellectual capital, extent of reliance on capitation, information system assets, financial 
capital, and organizational integration and affiliation. The researchers offer four policies 
that may assist in providing patient safety: 1) increase consumer demand by raising the 
visibility of safety; 2) increase consumer demand by setting new performance and 
performance reporting standards; 3) set minimum standards for information systems that 
can improve safety; and 4) increase demand for systematic care throughout the 
organization. The researchers reported that: 
The most important obstacle to error reduction and patient safety was 
medical socialization that makes errors seem unacceptable, which serves 
to provide evidence of failures of character, and that can rarely be admitted 
or discussed among physicians. This socialization leaves physicians 
emotionally isolated in their responses to errors and any lessons learned 
are obtained privately (Miller & Bovbjerb, 2002, p. 435). 
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Delay. Gender, and Age 
Reportedly, men and women respond differently to illness. Risberg et al. (1996) 
conducted a study examining distress and delay and it was found that women reported 
experiencing more distress than males but both men and women reported experiencing 
the most distress when treatment delay occurred before hospital admittance. There was a 
positive correlation between length of total delay and distress. 
There are a number of factors to consider in assessing how men will respond after 
receiving a diagnosis of prostate cancer. The identification of stressors, strength of 
coping skills, and the availability of an adequate social support system influences the 
management of a cancer diagnosis and treatment demands. Men are taught to respond 
differently to illness during their childhood than women. Beliefs and practices become 
entrenched. Many prostate patients must decide among several treatment options which 
may cause significant emotional struggle. Unfortunately, men too often neglect their 
health problems and do not seek medical care (Curtis, et al., 2003). 
More information on health behavior among men is needed. Present medical and 
behavioral research on men’s health has been under-informed on the daily experiences of 
men and their perceptions of health and masculinity as personal, cultural, and social 
constructs (Watson, 2000). 
A survey of 222 breast cancer patients who were all over the age of 55 was 
conducted in an examination on patient and physician interaction. In this study, 
treatment delay was considered 60 days from symptom onset to first treatment. Age was 
shown to be associated with treatment delays. Results showed that physicians spent more 
time with their younger patients, providing information and support, and were not as 
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responsive to older patients. Maly et al. (2004) reported that, in the United States, the 
population of those over the age of 55 is steadily increasing and this population is more 
likely than those younger to encounter disparity in breast cancer treatment. 
Reportedly, older women have a less than desired amount of breast cancer 
knowledge and encounter treatment disparity, which places them at greater risks for 
treatment delays. Patient-physician interaction may steer the inclination towards or away 
from treatment delays and disparities (Maly, et al., 2004). 
African-Americans. Barriers to Treatment, and Delay 
Dressier and Binden ( 2000) report that because of limited theory connecting 
biological factors with the cultural and individual, researching cultural diversity and 
health behaviors is unaccommodating. 
According to the Intercultural Cancer Council (2006), 31 percent of 
African- Americans live at or below the poverty level and, residing in poor 
neighborhoods renders African-American people to be five times more likely to 
present with advanced disease at diagnosis and not receive adequate treatment for the 
disease. 
The results of a review of literature on underserved African-American 
communities and strategies for cancer prevention identified barriers to care: 
1. Inadequate access to and availability of services; 
2. Competing priorities; 
3. Lack of knowledge of cancer prevention and screening recommendations; 
4. Culturally inappropriate or insensitive cancer control materials; 
5. Mistrust of the health care system; 
6. Fear and fatalism (Wolff, et al., 2003, abstract). 
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In the publication, Medical Letter on the CDC & FDA (2004), investigators 
reported on the status of delay of diagnosis and treatment among African-American 
breast cancer patients. As reported by the CDC and FDA, the chances of survival 
are likely to be decreased after a treatment delay of 3 or more months. After the 
patient-physician consultation, treatment was initiated within 2 months. 
African-American women are experiencing longer delays of 3 or more months 
due to what appears to be socioeconomic status (including health insurance status); 
marital status; and health behavior, history and available medical resources. The reasons 
for the delays must be further researched. 
A cultural analysis and a series of semistructured interviews were conducted 
among 750 low-income African-American and Caucasian women on cultural differences 
in breast cancer mortality. Based on the premise that annual mammography, primary 
care utilization, and prompt treatment facilitate more promising stage of disease and with 
no significant differences of these factors among the two groups of women, there was no 
difference in stage of disease at diagnosis. African-American women maintain cultural 
beliefs that more white than black women have breast cancer and that breast cancer 
results in rapid death. These beliefs interfere with African-American women’s pursuit of 
timely diagnosis and treatment (Barg, 2000). 
A difference in the duration of adjuvant chemotherapy among African-American 
women and Caucasian women was examined in a study including 136 early stage, breast 
cancer patients, whose white blood cell (WBC) counts were followed throughout 
treatment. The researchers reported the WBC for African-American women was much 
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lower than Caucasian women. The results indicated that African-American women 
needed longer durations of treatment than others (Hershman, et al., 2003). 
There are few studies assessing healthcare barriers and African-American, with 
the majority of the research focusing on populations of prostate patients such as Smith’s 
(1996) study. African-American men with higher socioeconomic status were found to 
perceive fewer healthcare barriers and more promptly sought medical treatment than 
African-American males with less socioeconomic status. 
Another study examining prostate cancer among African-American men received 
results that may be useful in the investigation of treatment delay. Assessing fear of a 
cancer diagnosis among African-American men, 60 percent of the subjects indicated 
serious concern about experiencing impotence and incontinence after treatment. 
(Parchment, 2004). 
African-American men experienced more delay from time of diagnosis to 
treatment than Caucasian men, due to a practice referred to as ‘watchful waiting,’ which 
is non-aggressive therapy and is utilized instead of more assertive treatment regimens. In 
2002, approximately 200,000 prostate cancers were diagnosed and an estimated 75 
percent of these cancers were localized or had not spread to other parts of the body 
(Parchment, 2004). 
In a study investigating African-American men’s health seeking behavior, 
Leininger’s Culture Care Diversity and Universality Theory and the Health Belief Model 
were used to examine social dimensions that influence motivation such as education, 
economics, religion and politics as well as the barriers to help-seeking behavior. A major 
identified barrier is African-American men’s mistrust of the health care system and 
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intervention that increases trust may be needed. Results of the study also found that 
significant others strongly influence African-American men’s health-seeking behavior. 
Specific cultural motivators such as targeted outreach and special health centers for this 
population can be established through social policy (Plowden, 2003). 
Environmental forces impact the quality of life for African-American men. In the 
U. S., African-American men die from homicide, suicide, AIDS, drug and alcohol abuse. 
Romantic competition for the available African-American men causes conflict in the 
lives of these men (Staples, 1995). 
With the exception of Native-American men, African-American men have the 
lowest life expectancy of all groups. When a man feels his masculinity may be 
threatened, he will ignore his illnesses and refuse medical treatments. African-American 
men receive inadequate medical care, even when it is pursued. Another health-impacting 
environmental force of hazardous waste sites that were studied, 75 percent were placed in 
African-American communities (Sabo & Gordon, 1995). 
Treatment Delay Summary 
Treatment response at an early stage of disease is important to positive health 
outcomes. From 30-50 percent of cancer patients will never begin chemotherapy. The 
most crucial phase of illness is between diagnosis and treatment. In 6-16 percent of 
study cases, after the diagnostic consultation, the first treatment exceeded three months. 
Lower survival is associated with 3-6 months delay. Health care professionals can 
provide patients with information on the safe amount of time they may need for 
decision-making, being clear on what is considered treatment delay. Longer delays are 
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linked to lower survival and advanced stage. Higher educated patients, cancer patients 
younger than age 50, and women experience shorter delay. Older age has been 
associated with treatment delay and disparity. 
There is a positive correlation between distress and total delay. As revealed in 
compliance studies, people have lots of reasons for noncompliance such as anxiety about 
treatment, forgetting about appointments, and experiencing fear of medical costs. 
Oncologists have reported concerns about noncompliance. Transportation can be a 
significant barrier. Health care costs and type of insurance can be problematic factors for 
many patients. Fully insured fee-for-service patients are able to initiate treatment quicker 
than HMO/copay patients who, in turn, receive care quicker than patients with public 
insurance. 
More research is needed on cultural diversity and health care. African-American 
men with higher socioeconomic status perceive fewer health care barriers but may have 
concerns about the physical risks of treatment. Significant others influence the health 
behavior of African-American men. African-American men, unfortunately, often receive 
inadequate medical care even when they pursue care and are sometimes subjected to 
watchful waiting. 
Social Support 
Extensive research has been conducted on social support since the late 1800’s, 
when researchers began to assess concerns on the breakdown of social ties and suicide 
and on the dynamics of community life and mental health status. These studies were 
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referred to as social integration research. Lower levels of social integration were 
associated with negative health risks. There are five theoretical perspectives on social 
support: supportive actions, appraisal, social cognition, symbolic interactionism, and 
relationships. These perspectives are described by their intellectual tradition, aspect of 
support emphasized, type of support measures emphasized, support operates, and the 
emphasis of stress buffering or main effects of support. Drawing consensus on a 
universal definition of social support has been a difficult endeavor for social scientists. 
Until agreement occurs, investigators must choose the definition or definitions that best 
fit the research at hand. For the purpoEse of this study, social support is any process 
through which social relationships might promote health and well-being (Cohen, et ah, 
2000). 
In African cultural tradition, the social support dynamic was manifested in the 
African-American community by the spirit of collective responsibility and this 
phenomenon has survived through the Middle Passage; the slavery period; the 
Progressive Era, with its utilization of the Black Codes; and the Great Depression to the 
present. Collective responsibility emphasizes the importance of helping others and 
caring for the sick, and safeguards the constructs of informal support, mutual aid, and 
group survival necessary only because professional health care has not been 
appropriately accessible to the African-American community (Carlton-LaNey, et ah, 
2001). 
It is common for the cancer patient to worry while waiting for the initial treatment 
appointment. Thinking about the side effects of the treatment, which can be severe, as 
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well as how the medical experience will significantly disrupt normal home and work life, 
is exceedingly stressful (NCCN, 2005). 
Baum (2004) discussed the importance of addressing three patient needs that will 
relieve distress. Patients have a need for various types of social support, to not have to 
suffer from disease symptoms, and to be provided a cure or a prolonged life. 
Weiss (1974) expanded the functions of social support as it relates to social 
relational provisions. The six functions offered are reliable alliance, social integration, 
guidance, opportunity for nurturance, reassurance of worth, and attachment/intimacy. 
Hopper (2003) utilized Laireiter and Bauman’s taxonomy of social support (social 
integration, social network, supportive climate, received and perceived support) to review 
definitions of social support. The researcher examined a number of studies which 
investigated the concepts of social integration and social network. Social integration 
includes the factors of marital status, contacts with friends and relatives, participation in 
formal and informal organizations and church membership. Social networks consist of 
spouse/partner, other relatives (extended family), friends, neighbors, coworkers, formal 
and informal caregivers and other health and welfare professionals. 
An extensive literature review and analysis on social support theory and related 
research was conducted. The author made the observation that all of the definitions of 
social support imply that support is of a positive nature. The numerous definitions were 
placed into five categories of social support: type of support provided, recipient’s 
perceptions, intentions of the provider of support, reciprocity, and social networks. Most 
social support research investigates the recipient’s perceptions of support and the 
majority of results indicate that social support does influence positive health-related 
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outcomes. It is important to note that support, even positive support, can be perceived as 
negative by the recipient. For some people in need of support, requesting and receiving 
support may be difficult. People provide support for many reasons. The more common 
reasons are due to dealings of empathy, obligation, or that similar support may be needed 
by the provider in the future. When operationalizing and measuring social support, 
researchers tend to examine only a fraction of the social support concept. The author 
encourages future researchers to focus on social support interventions that influence 
optimal health outcomes (Hupcey, 1998). 
Considerable research has been done on social support and cancer, using the more 
prevalent types of cancer such as the breast, colon, lung, and prostate cancers for 
investigation. Many of the following social support studies may identify cancers or other 
chronic illnesses studied other than lymphoma, for which there is limited research 
involving psychosocial associations. 
Waxler-Morrison (1991) found that the clinical stage of disease is significantly 
linked with survival, when social context at the time of diagnosis and the chances of 
surviving breast cancer four years later was examined. The association between the 
number of supportive personal and work relationships was found to be statistically 
important to survival. 
McCabe’s (1991) study results supported the hypothesis that patients who have 
the perceptions that they lack interpersonal support experience recurrent disease quicker 
than those whose perceptions are of possessing positive social support. This research 
focused on the association between the body’s immune system and the central nervous 
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system, which includes cognition and behavior, and the impact that these two major 
systems have on disease outcome. 
A questionnaire-based study investigated the effects of social support on health 
among 263 black South African patients, between the ages of 16 and 89, who were 
diagnosed with diabetes. The researchers reported in their findings that the more social 
support received, the better the general health and well-being of the patient (Westaway, 
et al., 2005). 
Types of Social Support 
There are three major types of social support interactions: 1) the communication 
of care and concern referred to as emotional support 2) the information provided to 
increase knowledge and to assist with decision-making referred to as informational 
support and 3) the provision of tangible goods referred to as instrumental support (House 
& Kahn, 1985). 
These particular types of supports are also referred to as functional support, when 
different types of supportive functions are provided through relationships and these 
functions may be helpful with resolving many types of problems. Functional support 
(emotional, informational, instrumental, companionship and validation) measures 
perceived support (available if needed) and received support (recently provided). 
Studying functional support helps to enhance understanding of support needs of different 
populations (Cohen, et ah, 2000). 
In an investigation on social support, networks, cohesion and health, reportedly, 
health status is related to the degree to which individuals are part of a social system. 
41 
Emotional and instrumental support are significantly related to health outcomes and 
social networks and mortality risks are closely associated (Berkman, 2000). 
Berkman (2000) also discussed Boissevain’s Social Network Model that explains 
how relationships with those of whom we are not intimately tied are just as important as 
our relationships with very close relatives and friends. This explanation expounds on the 
three major types of support: emotional, informational, and instrumental. Social 
networks can be examined by considering marital status, contacts with friends and 
relatives, religious affiliation, and membership in employment and voluntary 
organizations. The effects of social isolation on high risk chronic diseases places a 
person at a much higher risk of death than if the person was socially connected. Social 
workers may be able to effect positive change and reinstate humanitarianism back into 
the health care system by effecting biopsychosocial interventions and by advocating 
better integration between the health care system and the community through improved 
health policies. 
In one of the largest European surveys about women patients’ perceptions of their 
cancer treatment, results from over 30,000 respondents residing in 15 countries indicated 
that women do not have sufficient information about what to expect from cancer 
treatment and that most of the women were informed of their diagnosis in a consultation 
with a specialist physician. The patient’s spouse, followed by children, family, and 
friends were the most reported sources of support. The most negatively affected 
relationships were with employers. Single patients reported feelings of isolation 




A number of studies have shown that various psychosocial interventions have 
positive outcomes for cancer patients. The outcomes were idealized as feelings of 
well-being and cancer regression. Results of a study on emotional coping involving 
breast cancer patients who received psychosocial intervention were evaluated. The 
results showed that coping improved with intervention after a 4-month delay as well as 
with immediate intervention (Carlsson, 1994). 
Researchers studied changes in social activity and relationship satisfaction and 
examined how those changes impacted immune functioning, specifically, the tumor 
necrosis factor responses among 44 breast cancer patients. Measurements occurred at the 
time of cancer diagnosis, initial surgery, and 12 months later. The findings indicated that 
the higher the rate of social interaction experienced by the patient, the more stimulated 
the tumor necrosis factor responses, which strengthened immune functioning (Marucha, 
et al., 2005). 
Research results on coping and marital adjustment among prostate patients and 
their spouses revealed that, although the patients resorted to avoidance and denial 
behavior, the spouses positively responded to treatment demands. The majority of the 
men believed their marital relationships improved during the course of illness and 
treatment, despite reporting negative sexual changes among the couples due to impotence 
(Lavery & Clarke, 1999). 
A longitudinal study was conducted with 630 married subjects to examine 
occupational quality and whether it influences health-risk behavior. The mediating 
variables used were social integration, marital integration, and psychological control. 
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For women, social integration more strongly effected health-risk behaviors than marital 
integration and psychological control. For men, marital integration more strongly 
benefitted health behaviors (Wickrama, et al., 1997). 
Breast cancer patients were followed for one year post-surgery in an investigation 
on social support and adjustment to cancer. Four standardized inventories were utilized 
throughout the illness phases, from diagnosis to ongoing recovery. The study results 
showed that women needed continuous emotional support from their spouses throughout 
all phases, increasing support was needed apart from spousal support, and women 
worried about their spouses and children during the illness phases (Hoskins, et al., 1996). 
Living with others, especially children, provided motivation to accept aggressive 
cancer treatment. Parents with cancer, typically, do not want to cause major disruptions 
in the lives of their children (Yellen & Celia, 1995). 
Women in need of social support during cancer care may experience guilt for not 
caring for themselves well enough to avoid the cancer and neglecting to protect their 
loved ones from the distress that accompanies the cancer experience. Accepting care and 
support from others may exact challenges to the care receiver. Sulik’s (2005) qualitative 
study of women’s unequal participation in care-giving and care-receiving resulted in the 
suggestion that women redefine their concepts of care. 
Adult cancer patients, their spouses, and children responded to an assessment of 
psychological maladjustment during the diagnostic phase of illness. The severity of the 
illness indicated the level of distress experienced by the patients and their family. Risks 
for psychological maladjustment among the children were determined by sex of the 
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patient, sex of the child, and age. Adolescent girls whose mothers were the identified 
cancer patients experienced the most distress (Compas, et al., 1994). 
Lesbian breast cancer patients exhibited fewer difficulties with body image, 
receiving social support from partners and friends, and their perception of the health care 
system than heterosexual patients. The study compared the cancer experiences of lesbian 
and heterosexual breast cancer patients (Fobair, et al., 2000). 
In a study on social support networks, adults, aged 60 to 91, who identified 
themselves as lesbian, gay, or bisexual, reported receiving their emotional support from 
domestic partners and relatives and felt more positive about their overall health than 
those living alone. The receipt of support from those aware of their sexual orientation 
was preferred (Grossman, et al., 2000). 
Lesbians, diagnosed with cancer, tend to have feelings of discomfort with 
provider communication and treatment interventions. They report experiencing distress 
at having to disclose their sexual orientation, for fear of possible discriminatory 
treatment. Securing emotional support was also identified as difficult (Matthews, 1998). 
Formal support groups are frequently utilized to provide identified needs of the 
patient. Cancer patients are brought together in a group to discuss cancer-related issues 
in the hopes of fostering support and encouraging patients to use their individual 
resources (Weiss, 2003). 
Support groups, which are, typically, free services, provide emotional and 
informational support to those with similar issues. Professional social workers often 
facilitate these groups. The groups may decide how often to meet. Various types of 
groups are formed such as face-to-face, online or telephone. There are organizations that 
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demonstrate great creativity, their goals being to encourage commitment to the groups, 
bonding, relaxation, and enjoyment (Landay, 1998). 
Informational Support 
Finding successful methods to initiate and maintain patient involvement with 
prescribed care is important. Providing customized materials, patient instructions, or 
helpful information, specifically for enhancing retention, facilitates patients’ 
understanding their medical conditions and helps the physician provide treatment 
(Prounis, 2005). 
Mettler (1993) conducted a questionnaire-based investigation on the relationships 
between social support, informational support, and cancer treatment adherence among 46 
patients receiving chemotherapy. Findings revealed the patients were most influenced by 
their doctors; were satisfied with the support and information received, which was 
received most from nurses; that most of these patients admitted to experiencing great fear 
about their chemotherapy treatments; most experienced moderate side effects to the drug 
treatments; and that emotional despair was experienced due to hair loss. 
“Only 35 percent of patients receive instructions from their physicians on how to 
take medication” (Prounis, 2005, p. 140-141). Believed to be unintentional, the 
physician-patient visit, which is critical, is not managed well enough to ensure the 
patient’s complete understanding to comply with treatment recommendations. 
Research has shown that women prefer to have complete information (written or 
verbal) when diagnosed with invasive breast cancer. Psychosocial support is preferred as 
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most women respond with shock when hearing about their diagnosis (De Morgan, et ah, 
2002). 
Being involved with family members or friends who have experienced cancer 
promotes quicker responses to symptoms and less delay. Peer relationships can be 
effective at providing desired information that promotes improved health-seeking 
behavior (Bradley, 1998). 
Plass and Koch (2001) researched participation in formal social support among 
132 cancer patients, using a number of measurement tools. Patients who received 
psychosocial support reported wanting to obtain help with distress and coping with the 
illness and patients who did not pursue psychosocial support believed the informal 
support from family, friends, and physician was enough. 
Negative perceptions of the patient-provider relationship were examined in the 
Commonwealth Fund 2001 Health Care Quality Survey, which included 6722 
participants. Of the study population, 14.1 percent African-Americans, 19.4 percent 
Hispanic-Americans. 20.2 percent Asian-Americans, and 9.4 percent Caucasians believed 
they were treated disrespectfully by the provider. The study findings revealed that 
owning these negative perceptions caused unfortunate outcomes such as delay of care, 
receipt of less than optimal care, and noncompliance (Blanchard & Lurie, 2004). 
The National Council on Patient Information and Education Miscommunication 
reports that half of all patients forget what the physician verbally communicates to them 
and, after having left the consultation one hour later, an even higher percentage (60 
percent) could not precisely repeat physician instructions. Doctor-patient encounter 
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programs were designed to empower patients to fully participate in their own treatment, 
which will, ultimately, improve patient outcomes (Prounis, 2005). 
In an observation study examining new consultations between oncologists and 
bowel cancer patients in England, recorded dialogue was coded according to relevancy. 
A comparison analysis was conducted and the results indicated the patients’ active 
involvement through treatment decision-making revealed conflicting and unclear 
information about the treatment plan (Sandersa, 2004). 
Results from a quantitative study on patient expectations and physician support 
found that of 105 participants, 5.9 percent of the patients’ expectations were met, 
meaning they received exactly what they wanted from their physicians. The majority of 
the patients expressed satisfaction with the cancer consultation and there was no 
significant link to expectations of emotional or informational support (Brown, et al., 
1997). 
A comparative study was conducted to investigate the impact that communication 
has on patient outcome and to determine which of three randomly sampled groups 
— oncology physicians, oncology nurses or oncology social workers — was most effective 
in communication practices with cancer patients. They were asked to hold discussions on 
complementary therapies with their patients and then complete the mailed surveys. 
Survey information covered how many discussions were initiated, their comfort levels, 
and whether there were noticeable improvements in the patient-professional relationship. 
Social workers initiated more discussions than the other professionals (Harm, 2003). 
Support groups can be a source of empowerment for cancer patients as well as 
other informational sources such as the internet and patient advocacy. Patient support 
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group sessions; phone, email, or written patient reminders; and creative types of positive 
reinforcement are ways to assist in improving treatment adherence (Prounis, 2005). 
Researchers are exploring various group support techniques such as the 
Supportive-Expressive Group Therapy which aims to move patient groups through illness 
phases, transitioning them from negative coping to creative living, assertiveness, and 
celebration of living. Inspiring treatment compliance and decreasing delay of initial 
treatment is the goal of this technique (Kissane, et ah, 2004). 
Men, aged 48 to 85 years old and diagnosed with prostate cancer, completed the 
Supportive Care Needs Survey and reported the need for assistance with psychological 
concerns involving daily living, issues of sexuality, and informational support. All 206 
participants in the study were part of prostate cancer self-help groups. The younger men 
in the groups who lived in urban areas were found to require more psychological care 
than participants who were older and not living in urban areas (Steginga, et ah, 2000). 
Seeking knowledge about cancer and treatment from the Internet serves as a 
viable form of informational support, histserves, web forums, and chat rooms are 
convenient and, if preferred, anonymous methods of gamering support. Many of these 
internet sites allow for discussions among survivors or cancer peers and are, sometimes, 
monitored by experts or healthcare providers. When sites are not monitored, there are 
risks that unsupported cancer survivors could become unnecessarily victimized by fear or 
distress. With advancing technology, teleconferencing, which facilitates live video and 
audio may become more accessible to interested persons (Sharp, 2000). 
In a breast cancer study investigating the psychological benefits of Internet use 
for medical information among Caucasian, African-American, and Hispanic patients, 
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Internet use for medical reasons was associated with higher social support than use for 
other reasons or not using it at all (Fogel, 2003). 
Instrumental Support 
Health care research frequently looks for results to indicate or confirm health 
outcomes. Health outcome is defined by the World Health Organization (2005) as being 
able to afford health care services, having needed services available, and receiving 
culturally appropriate services. 
Factors that leverage health outcomes are accessibility, availability, affordability, 
and adaptability. Maintaining a respectable degree of these factors is an ever increasing 
challenge for many people with serious illnesses (Facion, 1999). 
Various reports indicate that approximately 45 million Americans are without 
health insurance and over 40 percent of African-American workers do not have coverage. 
Health care cost is rising and the black community suffers disproportionately (Malveaux, 
2005). 
Bhattacharya, Goldman, and Sood (2003) examined the quality of care received 
by HIV patients possessing public versus private health insurance. According to their 
findings, either type of insurance provides a safeguard from untimely mortality but that 
private insurance is a preferred safeguard over public. 
The majority of cancer patients receiving treatment experience some level of 
fatigue as a side effect of the treatment regimen. Approximately, a third of the 379 
respondents to telephone interviews on how fatigue impacts the lives of cancer patients, 
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indicated they were employed and 75 percent of these patients reported having to change 
their employment status due to the impact of fatigue (Curt, et al., 2000). 
Some cancer patients experience employment discrimination which was revealed 
in an investigation involving 422 patients who completed self-report surveys. The type 
of occupation is an important predictor of a patient continuing employment once a 
diagnosis is received (Rothstein, et al., 1995). 
Participation in clinical trials is an excellent instrumental support to explore. A 
major benefit of clinical trials involving African-Americans is opportunity to explore the 
design of medications specifically for African-Americans. BiDil is a drug developed to 
treat heart failure, which was an outcome of the African-American Heart Failure Trial. 
This trial, cosponsored by the Association of Black Cardiologists, was the first designed 
specifically for black patients (Witmyer, 2005). 
Special networks have been established such as the Lymphoma Support Network 
(LSN) that offer various instrumental as well as informational support. Peer support 
programs match cancer survivors with volunteers with similar disease experiences who 
provide emotional and informational support. The LSN may provide financial aid to 
assist with hardship concerns or needs not covered by insurance. For patients who may 
experience employment discrimination, patient advocacy and legal resource programs are 
available (Leukemia and Lymphoma Organization, 2006). 
Women aged 55-84 who lived alone tend to use the health care system for 
prevention and screening more than women living with a spouse, who were more likely 
to be diagnosed with advanced disease. In the examination of health, sociodemographic, 
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and psychosocial factors that predict stage at diagnosis, a significant predictor of disease 
stage was living arrangement (Moritz & Satariano, 1993). 
Social Support. Gender, and Age 
Current psychoneuroimmunological research supports the notion that being able 
to express emotions is beneficial to human health. Women tend to be more comfortable 
with developing close relationships and cultivating social networks than men. Men are 
more comfortable with activity-focused male-to-male relationships, tend to seek 
emotional support from women, and that social support may be more influential in men’s 
health than women’s (Hegelson & Cohen, 1996). 
Women prefer one-to-one communication when receiving information and would 
rather have family, friends, or cancer survivors to provide health information. Formal 
support interventions that may be especially beneficial to women include buddy systems 
with cancer peers, group projects such as an inspirational choir composed of cancer 
survivors, facilitation of natural support systems, and feminist pedagogical approaches 
(Hurdle, 2001). 
Women perceive their psychological adjustment following a diagnostic meeting 
with their physicians to be linked to the interpersonal skills of the physicians. The 
importance of patient-physician communication is emphasized (Mager & Andrykowski, 
2002). 
Markovic et al. (2004) focused on the principle of patient autonomy which 
explained that after the patient receives the medical knowledge about the disease, 
treatment, and prognosis from the physician, the patient is expected to make an 
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autonomous decision about the treatment path. The patient is able to weigh her treatment 
options while taking into account her own health beliefs. In this study, women tended to 
accept the advice of the primary care physician, if the patient-physician relationship was 
considered a positive, trusting one. Women assumed a passive role and relied on the 
medical professionals to make the decisions on treatment modalities, believing the 
clinicians were more capable and had a better understanding of the cancer and required 
treatment. 
Results of a study on the early psychological adjustment in breast cancer patients 
showed there is a relationship between social support and successful adjustment within 
the year following breast cancer diagnosis. A total of 87 subjects were assessed, through 
the utilization of questionnaires, before the diagnosis, followed up 8 weeks after 
receiving treatment, and then again after 9 months. Psychosocial intervention should 
occur for women at risk for psychological maladjustment following a cancer diagnosis 
due to their experience of emotional trauma, insomnia, fatalism, appetite loss, multiple 
fears, and suicidal ideation (Nosarti, 2002). 
The anticipation of a breast cancer diagnosis brings about emotional distress. 
Self-report questionnaires were used in a study conducted to determine what happens 
when patients receive a new diagnosis. They may experience feelings of disbelief, 
sadness, depression, anger, and become overwhelmed with thoughts of helplessness and 
hopelessness. They may have difficulty hearing or saying the word ‘cancer’ (Drageset & 
Lindstrom, 2005). 
Patient assessment for designing age appropriate interventions should include 
social support. As the average age of the U.S. population increases, cancer incidence 
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may increase. There are three factors that, reportedly, link advanced age and cancer 
development: time span of cancer progression, normal age-related changes that may 
resemble cancer, preconditions for cancer progression (Repetto & Balducci, 2002). 
Social Support and Bone Marrow Transplantation 
Bone marrow transplantation is used to treat aggressive cancers. While this 
treatment method may save lives, it can significantly reduce the quality of a patient’s life. 
Current research is attempting to address this issue and have found that social support 
received from family and spouses help with recovery from long-term complications 
(Case, 2004). 
One of the most aggressive treatments for cancer is autologous bone marrow 
transplantation. A study aimed to increase the body of knowledge on psychosocial 
impact on bone marrow transplantation. Forty-five participants received group support 
intervention and the healing process, which was assessed among five domains, was found 
to be beneficial. The domains were physical, psychological/emotional, vocational, 
social, and family/spousal intimacy (Feigin, 1999). 
Risk factors for poor quality of life outcomes (physical, sexual, occupational) of 
patients receiving allogeneic and autologous bone marrow transplants were greater age at 
transplant, lower educational level, and more advanced stage of disease. Questionnaires 
were administered to 200 bone marrow transplant recipients to gather information on the 
range of quality of life outcome. The majority reported having compromised quality of 
life compared to their premorbid status (Andrykowski, et al., 1995). 
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Bone marrow transplant patients were interviewed one week prior to transplant, 
and three, six, and twelve months after receiving transplants. Researchers assessed the 
psychosocial functioning of patients and close family members during a one-year span of 
time. Correlations between the patients’ biopsychosocial functioning and family 
members’ distress was most significant at the three month post-transplant period. All 28 
of the patients and their family members experienced high anxiety (61%) prior to the 
transplant. Less than half of the patients died during the one-year study (Keogh, et al., 
1998). 
Psychological and social factors of depression, BMT-related stress, chronic stress 
and resources in everyday life, pain-related coping behavior, and social support which 
were exhibited pre-BMT were significant predictors of increased vulnerability for the 
treatment-related side effects of moderate to severe mouth pain and anxious mood. In a 
longitudinal study, utilizing a self-rating scale, 63 patients were assessed daily (Schulz- 
Kindermann, 2002). 
Researchers interviewed 112 bone marrow transplantation candidates utilizing an 
F.I.T. assessment tool. The tool focuses on family functioning, individual psychological 
maturity, and the capacity to understand the transplant process. The relationship between 
psychosocial factors and survival among the BMT candidates were examined. Each 
candidate received on F.I.T. score. The lowest scores near three indicated poorer 
prognosis or survival while the higher scores near nine indicating the propensity of strong 
survival (Hoffman, 1999). 
A research team aimed to determine a patient’s emotional status before receiving 
a transplant utilizing a scale that screens for psychosocial issues in bone marrow 
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transplantation patients. The interests in patient management of care and care planning 
inspired this study. The ability to predict psychosocial problems during BMT, based on 
the scores from the scale, was associated with pre-BMT results (Molassiotis, 1999). 
In the researchers’ review of literature on social support, helpful social support is 
essential during in-patient hospitalization and the post transplantation period. Prior to 
undergoing autologous blood stem cell transplantation, ninety-nine patients were 
surveyed with a scale which focused on social support and illness. The scale indicated 
positive social support and negative social support. Utilizing Cox regression analysis, 
negative social support, identified by experiences such as criticizing, victimizing, and 
avoiding interactions, showed significant relationship to poor survival following 
autologous stem cell transplantation. However, there was no association between 
positive social support and survival (Frick, et al, 2005). 
Cultural Concerns and Social Support among African-Americans 
Joiner (2004) explicitly outlines the historical and present state of health care for 
African-Americans in the U. S.: 
African-Americans overcame insurmountable obstacles to defeat the racist 
Jim Crow system. Now, the fight for equal rights has turned to quality 
health care. African-Americans lead the nation in heart disease, obesity, 
cancers, stroke, diabetes, and kidney disease. The death rate for blacks is 
30 percent higher than for whites. There are many factors that contribute 
to health disparities, including diet, access to care, quality of care and the 
lack of minority health care providers. All these factors can be traced to 
a system that has historically devalued black life (Joiner, 2004, p. 18). 
Historical social maltreatment such as the Tuskegee Experiment, a 40-year 
syphilis study, funded by the government, which left African-American men untreated, 
has led African-Americans to distrust traditional health care services. Research studies 
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have indicated that, in general, African-American men have inferior health status, with 
28 percent without health insurance and 40 percent dying prematurely. Seeking the kind 
of health they need is challenging. These percentages are inclusive of all educational 
levels and socioeconomic status. Joiner (2004) further discusses provider bias: 
The 1999 Kaiser Family Foundation report found that 69 percent of 
physicians believed that the health care system rarely or never treats 
people unfairly based on an individual’s race/ethnicity. An Institute of 
Medicine report revealed that many doctors don’t consciously 
discriminate against patients. However, who gets what kind of care is 
often decided based on preconceived negative stereotypes about certain 
groups. The report found that provider bias, prejudice and stereotyping 
may contribute to health care disparities. Even those who were well- 
meaning demonstrated negative racial attitudes. The report cited a study 
in which doctors working in a clinical setting rated African-Americans, 
despite their income or education, as lazy, less intelligent, less educated, 
less likely to comply with medical advice and more likely to abuse drugs 
and alcohol (Joiner, 2004, p. 18-19). 
The National Cancer Institute has defined health disparity as discrepancies in the 
incidence, prevalence, mortality, and burden of cancer that exist among specific 
population groups in the United States. The groups can be identified by race, ethnicity, 
social class, disability, income, age, or sexual orientation (NCI, 2005). 
According to former President Clinton, by 2010, health disparities will be 
eliminated. It is 2006, less than four years away from the goal. African-Americans, to 
date, have little reason to trust that, in the very near future, genuine concern about quality 
of their health care and equal access in the U.S. health care system will be adequately 
corrected (Dept, of Health and Human Services Minority Resources, 2006). 
Study results on trust in the health care environment indicate patient trust predicts 
health-seeking behaviors, namely, preventive health and adherence to treatment 
recommendations. According to Thom (2004), trust is, first, a person’s 
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acknowledgement of being in a vulnerable situation and, second, feeling secure that an 
identified person will act in the vulnerable person’s best interest. To measure trust in the 
health care system, physician attributes involving trust factors were identified by patients. 
The ability to establish good rapport; to understand and empathize; to provide honest, 
complete information about the patient’s illness and health; and to actually serve in the 
patient’s best interests were important identified physician attributes that could inspire 
patient trust, which is essential for high quality health care. He estimates that patient 
trust is closely associated with patient adherence and this may explain hesitancy to 
pursue medical care, from prevention to surgery, among African-Americans, who may 
experience high levels of medical mistrust. 
A qualitative study on social support and elderly African-American cancer 
patients, determined that the types of social support used by this patient population has 
not been prioritized in current research. Hamilton et al. (2004) thinks middle-class 
Caucasians have typically been study subjects in research on types of social support 
experiences and that when African-American cancer patients are included in studies, the 
findings inappropriately indicate that these patients lack support. The subjects indicated 
the following types of social support were preferred: 
• Emotional support: the presence of others, encouraging words, distracting 
activities, protecting, monitoring 
• Instrumental support: offers of prayers, assistance to continue religious 
practices, assistance to maintain social roles, assistance to live at home 
• Informational support: church-sponsored support groups, family, friends, 
getting information on what to expect, how to manage symptoms, help to 
interpret information, validation of information received (Hamilton, et ah, 
2004, p. 792). 
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Research results on perceived racism and social support among 64 
African-American college students revealed that social support helped to control 
blood pressure reactivity during experiences of perceived racism (Clark, 2003). 
In a questionnaire-based investigation on health behavior involving 216 
African- American men, discrimination experiences were positively related to high levels 
of medical mistrust and that psychosocial, historical, socioenvironmental and healthcare 
factors must be examined to understand the health behaviors of African-American men 
(Powell, 2005). 
Data from Medicare claims for over 90,000 men diagnosed with prostate cancer 
were used to examine treatment changes during a time span of 10 years. Results 
indicated Caucasian men received routine follow-up treatment twice more than 
African-American men (Zeliadt, 2004). 
Fourteen African-American prostate cancer survivors were interviewed during a 
study on cultural beliefs and attitudes about complementary and alternative practices and 
products. Prayer was very important in coping with the stressors that were associated 
with prostate cancer (Jones, 2005). 
There was support found for a study hypothesis that African-American men 
would be more likely than Caucasian men to place their lives in God’s care and not 
concentrate on the future as much as the present. The researcher investigated factors 
that contribute to health attitudes and behavioral outcomes by administering time 
perspective and religious problem-solving instruments (Flournoy, 2002). 
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The structural and political conditions that create inequities in health are typically 
ignored and, instead, the focus is placed on the behaviors of African-Americans that 
result in negative outcomes (Barg, 2000). 
In a qualitative study on coping strategies of 196 African-American women, the 
findings provided multiple behavioral strategies which explains African-American 
responses to rendered inequities: 
• Internal coping - resting on faith (relying on prayer and spirituality), 
standing on shoulders (drawing strength from African-American 
ancestors), valuing oneself (sustaining a positive self-image) 
• External coping - leaning on shoulders (relying on social support) 
• Specific coping - role flexing (altering their outward behavior or 
presentation), avoiding (diminishing contact with certain people and 
situations), standing up and fighting back (directly challenging the source 
of the problem) (Shorter-Gooden, 2004, p. 406). 
In a qualitative study on social support intervention among African-American 
women, three focus groups of 18 were conducted with lower income, socially isolated, 
and pregnant subjects. Stressors and types of intervention to address those stressors were 
investigated and were identified as typical basic needs. They reported coping through 
their relationships with God, their mothers, and some with their male partners. The 
expectations were for their identified support systems to be there for them, indulge and 
listen to them. The social support interventions developed through this study, were 
four 30-60 minute sessions provided throughout the pregnancy, which consisted of 
skill-building for self-esteem and accessing support and providing a support coordinator 
assigned to acknowledge and value the subject (DeJoseph, et al., 1996). 
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Henderson (2003) compiled information on support networks that 43 
African-American breast cancer support group participants used. In the data collected, 
the majority of the women were married, possessed a high school education or less, and 
had incomes of $30,000 to $59,999. The majority reported God as their most important 
source of support and reported using the following a great deal: talking to someone to 
find out more about the situation, talking to someone who could do something concrete 
about the problem, talking to someone about how they were feeling, asking a respected 
relative or friend for advice, accepting sympathy and understanding from someone, and 
getting professional help. 
African-Americans tend to believe that when cancer is diagnosed, death is certain. 
This belief is a basic feature of the concept of cancer fatalism, which is considered a 
barrier to treatment. Powerful research on fatalism and spirituality has been conducted 
by Powe (2003) and her colleagues. 
Spirituality among African-Americans significantly enhances coping with racial 
stress and influences positive health outcomes. This concurs with the findings of the 
above studies (Bowen-Reid & Harrell, 2002). 
A review of literature was conducted on spiritual beliefs that influence the 
treatment decisions of African-Americans because information on and understanding of 
such cultural dynamics can be beneficial for health care providers. The belief that God is 
ultimately responsible for all aspects of human health and that the physician is ‘God’s 
instrument’ provides a source of support, comfort, and a productive way to influence 
healing. Results indicated that African-Americans are more likely than Caucasians to 
place great importance on healing through prayer, that the will of God is most important 
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in their recovery, and that they have relied on this higher degree of spirituality since the 
historical times involving oppression (Johnson, 2005). 
Social Support Measurement Instruments 
In this study, social support is defined as any process through which social 
relationships might promote health and well-being (Cohen, et al., 2000). Three models 
were considered in order to construct an index to measure social support factors, focusing 
on the evidence of the existence of social support during the time span between diagnosis 
and initial treatment. 
Supportive Care Needs Survey 
The Supportive Care Needs Survey was designed by Bonevski, et al. (2000), to 
measure the needs of cancer patients and to also assess health services and treatment 
delivery. The 59 items in the survey are grouped into five categories: psychological 
needs, health system needs, physical and daily living needs, patient care and support and 
sexuality. In this questionnaire, the respondents are able to educate and offer 
explanations on whether their needs were satisfied and whether the amount of help 
needed was low, moderate, or high (CMHSR Measures Collection, 2006). 
Social Support Behaviors Scale 
The Social Support Behaviors Scale was designed in 1987 by Vaux, Riedel, and 
Stewart and intended to measure five dimensions of available social support from family 
and friends: emotional, socializing, practical assistance, financial assistance, and 
advice/guidance. Subjects completing the scale are asked to consider how likely family 
62 
members and/or friends would provide assistance in 45 different ways listed in the 
instrument. The scale’s focus is on perceived social support and covers the factors 
important to emotional, informational, and instrumental support (Vaux, et al., 1987). 
Medical Outcomes Study: Social Support Survey Instrument 
The Medical Outcomes Study: Social Support Survey Instrument was developed 
for patients with chronic conditions who participated in a two-year study on medical 
outcomes. The self-administered instrument is brief and measures how often (none of 
the time, little of the time, some of the time, most of the time, and all of the time) various 
kinds of support may be available to the patient. The survey measures five social support 
dimensions: emotional/informational support, tangible support, affectionate support, 
positive social interaction and additional items. The statements under each dimension are 
intended to gather information indicating support available to the patient (Rand, 2006). 
Summary of Social Support 
Female cancer patients worry about their spouses and children and experience 
self-blame and guilt about their illnesses. Cancer patients can become extremely upset, 
worry about the side effects of treatment, and how their lives will be disrupted. People 
need a variety of types of social support. 
There is no consensus on the definition of social support. The most studied area 
of social support is perceived and received care. Social support and health outcomes are 
significantly related. Some say the number of supportive relationships is related to 
survival but other researchers believe the quality of or perception of supportive 
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relationships is more significant. The most negatively affected social relationships 
among cancer patients are with employers. 
Family or friends with past experiences with cancer elicit quicker responses to 
symptoms and less delay among those in receipt of their support. Religiosity and 
spirituality influence health outcomes. Spouses of prostate cancer patients experience the 
same distress as the patient but positively responded to treatment demands, which 
allowed them provide effective intervention with their husbands. Living with others 
provides motivation to get treatment. Studies on living alone had conflicting results. 
Having to divulge their sexual orientation the health care professionals is discomforting 
for patients who are gay, and population primarily received emotional support from 
domestic partners, family and friends. 
Close to 50 percent of U.S. population do not have health insurance. Clinical trial 
participation can be a viable treatment option. Bone marrow transplantation patients 
experience significant quality of life challenges. High levels of pretransplant anxiety 
among patient and family is a predictor of increased risk for posttransplant 
complications. There is limited research on social support, lymphoma and bone marrow 
transplantation patients. 
Negative stereotypes of certain groups are still present in the health care system. 
African-American people have historically depended on support from extended family, 
which is a distinguishing characteristic among this population. African-American cancer 
patients have their own translations of emotional, information, instrumental support, as 
well as, internal and external coping and extended family and church/spirituality are 
important support systems in the African-American community. There is a gap in 
research on social support during all stages of illness and on the political conditions 
responsible for health disparity. 
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Social Work and Oncology 
Social Work Profession and Mission 
The National Comprehensive Cancer Network (NCCN) provides detailed medical 
treatment guidelines for cancer specialists. This network also presents a version written 
specifically for cancer patients. Information on patient distress is included in the 
treatment guidelines. The Association of Oncology Social Work, established in 1984, is 
an international organization with over 900 social workers. This organization provided 
the distress guidelines for NCCN and was organized to provide comprehensive services 
to patients and families throughout all phases of the cancer experience. Services are 
provided in a variety of settings including cancer centers, hospitals, home health and 
hospice programs, community-based agencies, and private practice settings. The 
association’s mission is to facilitate quality psychosocial care of cancer survivors and 
their support systems by focusing on education, networking, advocacy, research, and 
resource development (Association of Oncology Social Work, 2006). 
The National Association of Social Workers, as well as the National Association 
of Black Social Workers, each has components within their programs to address health 
and cancer issues. These organizations provide training, research, and advocacy support 
for social workers who provide services to cancer patients. 
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Psychosocial Intervention 
After the patient receives a cancer diagnosis, information about support services 
is traditionally provided. The hospital or clinic may offer resources such as support 
groups; financial, nutritional, and pastoral services; and patient and family counseling. 
The patient is responsible for contacting the support services they feel would assist in 
their overall medical care unless the hospital or clinic takes the initiative to set up these 
services for the patient (Winship Cancer Institute, 2006). 
Interviewing patients to identify their primary support persons should be 
conducted by social workers, who would then strongly encourage the patient and the 
health care team to include these significant others for positive support throughout the 
cancer care experience (Davis, 2004). 
An investigation was conducted on the effectiveness of structured telephone 
interviews by social workers for the purpose of prescreening patients before their first 
cancer treatments at a major cancer center. Substantive information on the patient’s 
support systems was gathered and patient rapport was promptly established by the social 
workers. The researchers were able to gather enough pertinent information about the 
patients to identify assistance that could be provided before or the patients’ initial visit 
(Korcz, 1998). 
A study evaluating hospital social work, specifically examining patient 
acceptance of consultation by a social worker, was conducted. Of the 273 cancer 
patients, 78 percent considered consultation by the social workers beneficial. Ninety-six 
percent of these patients felt that consultations should be offered to all cancer patients, as 
many patients were unaware of hospital social workers. Patient topics of interests in the 
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consultations were on medical rehabilitation, social law, coping strategies, and individual 
psychosocial issues (Bonninghaus, et al., 1999). 
The results of a literature review on usage of psychosocial oncology services 
revealed that only 15 to 25 percent of cancer patients may use the services. Many 
patients are concerned with instrumental support. Methods on increasing access to and 
usage of social work services among all groups of people should be further explored 
(Cwikel, 1999). 
Beder (1995) examined, in a quantitative-descriptive study, the diverse 
demographic features and the relationship between social support perceptions and breast 
cancer adjustment among African-American women. As a professor of social work, the 
researcher was most interested in exploring the implications for social work intervention. 
Women, aged 65 or younger, who were diagnosed for the first time, had mastectomies, 
were socioeconomically disadvantaged, and covered by Medicaid or Medicare were 
recruited from hospitals in New York City. Fifty women were 3 months postmastectomy 
and fifty were 12 months postmastectomy. The Psychosocial Adjustment to Illness 
Scale, the Interpersonal Support Evaluation List, and the Social Work Involvement Scale 
were utilized in the study. Higher perceptions of social support caused positive 
adjustment to the illness. Social work utilization in the hospitals was low and, ironically, 
did not have as a significant role as expected in this study. 
Community Intervention 
In this 21st century, the social work profession has competition from other health 
care professions for the crucial roles of traditional medical social work such as 
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psychosocial therapy, intake and discharge planning, and community liaison work. The 
changing healthcare system is adapting to the managed care protocol that influences the 
duration of hospital stays, medical costs, and how the provision of social work services 
should be handled (Sulman, 2001). 
Rizzo examined utilization reviews and focused on social work roles in health 
care settings. The findings indicate that because of decreased lengths of stay and 
increased tension over how health care budgets should be utilized, hospital-based social 
work, which is not considered income generating, may suffer casualties to hospital 
downsizing (Rizzo, 2000). 
Zebrack (2000) explains how social workers must respond to such dilemmas: 
“Caught in conflicts that challenge them to reconcile simultaneous commitments to client 
service/empowerment and institutional conformity, social workers must establish a more 
powerful position to negotiate institutional and public policies that uphold the primacy of 
a core social work ethic” (Zebrack, 2000, p. 89). 
One way oncology social workers can hold more powerful negotiating positions 
is by staying current with important research. Participating in, as well as staying current 
with, intervention research may be crucial to gathering changing information on patient 
needs which include groups of people - minorities, non-traditional, non-middle-class 
groups - not sufficiently represented in research (Cwikel, 1999). 
Berkman (2000) stated in her work entitled, Social Support, Social Networks, 
Social Cohesion and Health, that social work has made important contributions in the 
area of physical and mental health. Social workers provide creative and effective 
solutions to complex health problems involving social relationships. 
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The attempts to improve health care access and participation among people of 
color have not been easy tasks for social workers. Wells (1977) discussed the state of 
health care and social work in the United States. Throughout the past centuries, people 
of color have struggled to get and keep all provisions covered within their human rights. 
The social workers’ struggles are the same in the delivery of services in health care. 
There must entail a holistic response to all factors that contribute to the lack of optimal 
health. Social workers must teach patients how to use the health care system in ways that 
benefit them or to change a system that does not work for them. 
Not all patients are able to receive hospital care and the number of people 
receiving outpatient cancer care has increased. These patients return to their 
communities, more than likely, in need of support services. In response to changing 
client needs, social work professionals, with cancer care knowledge and experience, are 
in advantageous positions to act as liaisons with community agencies and to develop new 
community resources (Clark, 2000). 
Theoretical Framework 
In her career as a social worker, Jane Isaacs Lowe (1997) has focused on and 
conducted research on community-oriented practice. Lowe designed the Social-Health 
Model to provide a forum for enhancing the education of social workers in health care 
practice and believes that health is not only a function of human biology and physiology 
but, significantly, involves the social and physical environment. A community is a group 
of people with common interests and social workers must examine the issues of 
community and public health and claim leadership roles in the health care arena, with the 
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specific goal of improving health via the home, work, and social environments of the 
individual. 
The Social-Health Model facilitates the examination of links between health, 
illness, and the social functioning of individuals, groups, and communities. Health 
impacting social problems such as poverty, substance abuse, violence, and discrimination 
must have interventions designed to further prevention and health promotion, utilizing a 
community-oriented framework. The Social-Health Model creates a path for social 
workers to “identify themselves as primary care providers who possess expertise in” 
community practice, education, and research (Lowe, 1997, p. 217). 
Improving the health of African-Americans, who are experiencing disturbing 
incidence and mortality rates in major chronic illnesses, will necessitate a 
community-oriented approach. The significant economic, environmental, and 
political problems that result in health disparity indicate that the personal lifestyles and 
behaviors of African-Americans are not the only concerns in need of examination and 
resolution. The Social-Health Model demonstrates the importance of psychosocial 
interventions in primary care and requires the promotion of support from all community 
shareholders (Lowe, 1997). 
The Social Cognitive Theory has been a platform on which many theories have 
been supported and will provide the basis of the framework for this study. Bandura 
(1994) theorized that a person’s behavior is determined by a combination of cognitive, 
behavioral, and environmental factors. According to this theory, which is frequently 
utilized in health care research, a patient, equipped with social learning experiences, 
possesses a core set of determinants for health behavior. These determinants include 
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knowledge of health risks and benefits; perceived self-efficacy; outcome expectations; 
health goals; and perceived facilitators. 
The Social Cognitive Theory stresses the importance of integrating significant 
causal factors and core determinants in order to understand how human beings forge 
decisions. A lymphoma patient may seek to understand a given diagnosis, staging of the 
disease, and treatment recommendations. The comprehension gained may provide an 
increased capability to make prompt, appropriate health decisions, which would then 
allow the patient to proceed on an evaluative journey that processes all expected benefits 
and losses. The patient is, thereby, better equipped to determine short term and long term 
health plans based on personal needs and/or desires. Throughout this journey, 
perceptions about the social support network are processed and supportive social 
interactions are utilized to cope with and/or overcome the illness. 
This research sought to examine the influence that a variety of supportive social 
interactions may have on health behavior during the time span between the diagnostic 
consultation and the patient’s first cancer treatment. The Social Cognitive Theory 
provides a conceptual framework for investigating connections between psychosocial and 
behavioral determinants and outcomes. 
Research studies, utilizing the Social Cognitive Theory, have been conducted on 
countless health topics, especially with adherence studies: children’s dietary behavior, 
exercise management interventions among the elderly, patients receiving cardiovascular 
treatment, health education for HIV infection, and quality of life outcomes through 
intervention with cancer patients. This framework is useful in explaining and predicting 
behaviors and examining behavior change. 
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The Social Cognitive Theory has been criticized for providing a “static view of 
behavior change,” (Gebhardt & Maes, 2001, p. 528-536) in that, once self-efficacy is 
established by an individual, an assumption is made that the expected behavior change 
will definitely occur. The theory has also been criticized for examining behavior on an 
individual level rather than group levels but the constructs of collective efficacy and 
social change are clearly explained within the theory. 
Barbara Powe (1997) designed the Powe Fatalism Model to provide a framework 
for examining cancer fatalism which is the belief that a cancer illness is beyond the scope 
of human control and that a diagnosis of cancer means certain death. Cancer fatalism is 
an identified barrier to cancer screening and treatment, which may cause significant 
treatment delay among cancer patients. African-American cancer patients, with their 
extraordinary history of slavery in this country, possess lived experiences of racism and 
poverty and these experiences along with possible feelings of hopelessness and despair 
have been identified as evidence of fatalism. 
Finding meaning in life through a higher being, exercising prayer and faith, 
and attending church are associated with having spirituality. Powe (1997) and her 
colleagues believe that “hope may be the common denominator that binds the concept 
of fatalism and spirituality” and this coping mechanism may assist in positively 
modifying health-seeking behaviors (Powe, 1997, p. 142). 
The social work profession will continue to support, enhance, and develop 
community-oriented services dedicated to improving overall health and well-being. 
Particular attention must be given to those with special needs such as African-American 
patients considered for bone marrow transplantation who may not have access to quality 
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care, who may be hesitant to pursue care due to feelings of anxiety and medical 
mistrust, or may pursue care but are deemed poor candidates for the transplant due to 
lack of adequate support systems (single mother without childcare assistance). The 
Social-Health Model assumes the importance of facilitating support throughout all 
possible levels of functioning - the individual, economic, political, environmental, and 
other levels. 
There is synergy with the Social-Health and Social Cognitive models, in that, 
both assume the importance of examining integrating causal factors for increased 
comprehension of concerns and for providing a framework for the creation of appropriate 
interventions to address multidimensional issues that concurrently impact individuals and 
communities. 
Powe’s Fatalism Model provides excellent opportunities to understand concepts 
of religion, spirituality, and health that have traditionally been overlooked in research 
which has included African-American participants. 
CHAPTER III 
METHODOLOGY 
Chapter III describes the methods and procedures used in the investigation on the 
influence of social support on treatment delay among African-American patients 
diagnosed with lymphoma. The chapter is divided into the following sections: research 
design; description of the site; sample and population; instrumentation; treatment of the 
data; and limitations of the study. 
Research Design 
The descriptive and explanatory research design was used in this study. This 
study was designed to collect data in order to describe and explain the influence that the 
presence of supportive social interactions may have on the timely initiation of treatment 
among African-American lymphoma patients who are considered for bone marrow 
transplantation at Emory University Healthcare and the Winship Cancer Institute. 
Description of the Site 
This research study was conducted in Atlanta, Georgia, a large urban 
metropolitan area. This research was part of an IRB approved, ongoing study on 
treatment outcomes for patients with non-Hodgkin’s lymphoma at Emory University 
Healthcare and the Winship Cancer Institute. Existing data for this study was obtained 
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from the Emory University Healthcare databases containing medical information on 
oncology patients at the Winship Cancer Institute, Crawford Long Hospital, Emory 
Clinic and Emory Hospital. A data manager has direct access to data that was requested 
and made available to the investigator for this study. 
Sample and Population 
The target population for this research will be composed of lymphoma patients 
considered for bone marrow transplantation, with special emphasis on African-American 
patients. These patients have been diagnosed with relapsed lymphomas, with the three 
major diagnoses being relapsed follicular lymphoma, relapsed Hodgkin’s lymphoma and 
relapsed diffuse large B-cell lymphoma. These diagnoses, depending on the stage of the 
disease, requires transplantation as standard treatment. The Emory University Healthcare 
databases house patient data including extensive social work assessments only on 
lymphoma cancer patients considered for transplantation. Demographic data and the 
bone marrow transplantation social work assessments on 119 patients were collected, 
utilizing nonprobability sampling. Bone marrow transplantation social work assessments 
are those records that contain the following patient information: demographic, marital 
status, insurance, employment status, diagnosis and treatment, family of origin, support 
and caregiver, compliance status, financial concerns, hobbies and interests, coping skills, 
religious affiliation, history of psychiatric treatment, substance use, legal history, 
veteran’s status, lodging and transportation plan, advance directives, resources given to 
the patient, assessment, and recommendation and plan. 
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Oncology patients provided consent to medical information storage in the 
databases of the Emory University Healthcare. All patient identifying information used 
for research is protected. The Health Information and Portability Accountability Act of 
1996 (HIPAA) identifiers are masked. Masked information consists of patient name, 
patient ID, patient address, patient phone number, patient social security number, patient 
corporate identifier, and medical record number. 
Instrumentation 
This study examined the influence of social support (emotional, informational, 
and instrumental) on the time span between diagnosis and initial treatment among 
lymphoma patients considered for bone marrow transplantation. The hypothesis for this 
study was that there was a statistically significant relationship between emotional, 
informational, and/or instrumental support and the amount of time between receiving a 
lymphoma diagnosis and receiving initial recommended treatment. 
The research study utilized an inventory tool, the Patient Support Index, which is 
a compilation of informational items obtained from established social support 
measurement instruments. The inventory was designed to collect data pertinent for this 
study. Data was read from the social work assessments and hematology notes (dates 
were collected for the New Patient Consult and the following appointment) and recorded 
on to the Patient Support Index in order to show evidence of support that may have been 
received by the patient. 
Section I of the inventory consists of eight items (1 through 8) concerning age, 
gender, race/ethnicity, diagnosis, stage of disease, date of diagnosis, date of initial 
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treatment, and the time from diagnosis to initial treatment. These items will provide 
information for the presentation of a patient demographic profile and determines the 
amount of treatment delay. 
Sections II (Emotional Support), III (Informational Support), and IV 
(Instrumental Support) consists of the last thirteen items which will measure to what 
extent emotional, informational, and instrumental support exists among the patients who 
may or may not have experienced treatment delay. 
Measures for Demographic and Patient Information 
Demographic and patient information used in this study were defined based on 
guidelines by the National Cancer Institute’s Surveillance, Epidemiology, and End 
Results (SEER) and guidelines established by the IRB approved lymphoma study with 
Emory University School of Medicine and Winship Cancer Institute. This information 
was operationalized as follows: age (date of birth to date of diagnosis); gender (male or 
female); race/ethnicity (black, white, Hispanic, Asian/Pacific Islander, other); diagnosis 
(documented diagnosis); and stage of disease (documented pathologic stage). 
Measures for Social Support 
Social support is defined in this study as any process through which social 
relationships might promote health and well-being (Cohen, et al., 2000). Functional or 
available support, a dimension of social support, is further delineated to emotional 
support (availability of people who can allow discussions of feelings and express care 
and acceptance towards an individual having problems), informational support (provision 
of information that may be useful for solving problems), and instrumental support 
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(provision of tangible assistance such as child care or home care). All of the social 
support variables allow for the theoretical benefits attributed to each of the three 
functional supports examined. 
The social support variables used in this study were operationalized as follows: 
spouse/partner (married, domestic partner, single, separated, widowed, divorced, 
unknown); children (adult children, children less than 18 y.o., none); other support 
(extended family-kin and non-kin, friends, organizations); church/spiritual (church 
attendance, personal prayer, visits with clergy, none); clinician (physician, nurse, social 
worker, none); formal peer support (cancer peer interaction, no cancer peer interaction); 
formal group support (support group attendance, no support group attendance); cancer 
resources (online resources, resource center, printed materials, other, none); employment 
status (employed, self-employed, homemaker, retired, disabled, unemployed, unknown); 
basic needs (place to live, access to food/prepared meals, available transportation, 
childcare assistance); health insurance (private, public, none); living arrangement (live 
with others, live alone); and clinical trials (participating in a clinical trial for lymphoma, 
not participating in a clinical trial for lymphoma). 
Measure for Initial Treatment Delay 
The examination of the link between duration of symptoms and survival among 
approximately 3000 women provides a useful study model for measuring delay. The 
16-year study’s hypothesis stated that, among the subjects, those with duration of 
symptoms 12 weeks or longer would result in worse survival rates than the subjects with 
less delay. Existing data was extracted from the hospital’s database and delay intervals, 
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specifically, the interval between onset of symptoms and first treatment (total delay) was 
examined, while noting any influence on survival. Statistical analysis was conducted 
using the chi-squared test (assessed delay with cut-off of 12 weeks and 26 weeks) and log 
rank test (assessed influence on survival of delay) and multivariate analysis using the 
stepwise Cox regression model (assessed survival from diagnosis). The results showed 
that the relationship between longer delay and worse survival was statistically significant. 
The reported survival rates were: 1)51 percent for delay less than 12 weeks; 2) 44 
percent for delay 12-26 weeks; and 3) 40 percent for delay greater than 26 weeks 
(Richards, et al., 1999). 
The measure used in this study for initial treatment delay is as follows: time from 
diagnosis to initial treatment (number of weeks elapsed, less than 12 weeks, 12 to 26 
weeks, more than 26 weeks). 
Treatment of the Data 
Statistical treatment of the data employed descriptive statistics, including 
measures of central tendency, frequency distribution, and cross tabulation. Statistical 
analysis were performed by using the Statistical Package for Social Sciences. The Chi 
squared test was used to assess delay (Richards, 1999) and logistic regression analysis 
was used to test the hypothesis and determine if social support explains differences in 
treatment delay (Mertler & Vannatta, 2001). 
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Limitations of the Study 
This study was dependent on the accuracy and completeness of the medical data 
previously collected by the hospital social workers. The existing data may not include 
information on all of the study measures. 
CHAPTER IV 
PRESENTATION OF FINDINGS 
The purpose of this chapter was to present the findings of the study in order to 
describe and explain the influence that the presence of supportive social interactions may 
have on the timely initiation of treatment among lymphoma patients who are considered 
for bone marrow transplantation. This chapter presents the findings of the study. The 
findings are organized into two sections: demographic and clinical data; and research 
question and hypothesis. 
Demographic and Clinical Data 
This section provides a profile of the study population. Descriptive statistics were 
used to analyze the following: age group, gender, ethnicity, marital status, children, 
employment status, diagnosis and stage of disease. 
A target population for the research was composed of lymphoma patients 
considered for bone marrow transplantation and had at least one consultation with a 
social work clinician, at which time information was provided for a complete social work 
assessment. 
These patients provided consent to medical information storage in the Emory 
University Healthcare databases. The bone marrow transplantation social work 
assessments and additional social work notes regarding the lymphoma patients are 
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Demographic and Clinical Characteristics of the Study Population 
Variable Frequency Percent 
Age Group 
18-30 13 10.9 
31-50 42 35.3 
51-70 63 52.9 
Over 70 1 .8 
Gender 
Male 68 57.1 
Female 51 42.9 
Ethnicity 
Black 27 22.7 
White 78 65.5 
Hispanic 5 4.2 
Asian 1 .8 
Other 8 6.7 
Marital Status 
Married 76 63.9 
Never married 21 17.6 
Widowed 4 3.4 
Divorced 13 10.9 
Separated 2 1.7 
Domestic partner 3 2.5 
Children 
None 18 15.1 
Under 18 years 35 29.4 
Over 18 years 66 55.5 
Table 1 (continued) 
Demographic and Clinical Characteristics of the Study Population 
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Variable Frequency Percent 
Employment Status 
Employed 51 42.9 
Unemployed 26 21.8 
Self-employed 3 2.5 
Retired 16 13.4 
Homemaker 3 2.5 
Disabled 20 16.8 
Health Insurance Status 
None 5 4.2 
Public Insurance 28 23.5 
Private Insurance 86 72.3 
Diagnosis 
Hodgkin’s 32 26.9 
Follicular 12 10.1 
Diffuse Large B-Cell 51 42.9 
Other NHL 24 20.2 
Stage of Disease 
Stage I 5 4.2 
Stage II 23 19.3 
Stage III 23 19.3 
Stage IV 32 26.9 
Unknown 36 30.3 
Major Emotional Support 
Family 99 83.2 
Extended family 10 8.4 
Friends 8 6.7 
Church/Spiritual 
Personal prayer 56 47.1 
Church attendance 41 34.5 
Visit with clergy 2 1.7 
None 20 16.8 
Table 1 (continued) 
Demographic and Clinical Characteristics of the Study Population 
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Variable Frequency Percent 
Clinician Support 
Nurse 94 79.0 
Social Worker 10 8.4 
Physician 15 12.6 
Living Arrangement 
Live alone 12 10.1 
Live with others 107 89.0 
As indicated in Table 1, the typical patient in this study was a 51 to 70 years old, 
married white male with adult children. This typical patient was employed, had private 
health insurance, lived with others, received the diagnosis of relapsed diffuse large B-cell 
lymphoma, and was either in stage IV of the disease or stage was unknown. The major 
source of emotional support was received from family members, personal prayer was 
most important, and clinician support was, more than likely, received from nurses. The 
following tables include frequency distributions the results of statistical analysis of 
demographic and clinical variables. 
Research Question and Hypothesis 
There was one research question and one null hypothesis in the study. This 
section provides an analysis of the research question and a testing of the null hypothesis. 
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Research Question: Does having access to emotional, informational, and/or 
instrumental support decrease the amount of time between 
receiving a lymphoma diagnosis and receiving initial 
recommended treatment? 
Null hypothesis: There is no statistically significant relationship between 
emotional, informational, and/or instrumental support 
and the amount of time between receiving a lymphoma 
diagnosis and receiving initial recommended treatment. 
In this study, social support has been defined as any process through which social 
relationships might promote health and well-being. Emotional, informational, and 
instrumental support are components of functional support which measures perceived 
(available if needed) and received support (recently provided) (Cohen, et al., 2000). 
In this study, treatment delay (total delay) was defined as the time interval that 
occurs from the beginning of symptoms to the start of professionally recommended care. 
Treatment delay can best be explained utilizing the following three intervals: 1) less than 
12 weeks for acceptable time elapse; 2) 12 to 26 weeks for significant delay; and 3) more 
than 26 weeks for advanced delay. 
Table 2 is a frequency distribution of the time since diagnosis to initial treatment 
among 119 lymphoma patients considered for bone marrow transplantation. Table 2 
indicates the type of delay experienced by these patients. 
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Table 2 
Time since diagnosis to initial treatment 
Variable Frequency Percent 
<12 weeks 108 90.8 
12-26 weeks 9 7.6 
> 26 weeks 2 1.7 
Total 119 100.0 
As shown in Table 2, lymphoma patients who experienced less than 12 weeks 
delay was 90.8%. Lymphoma patients who experienced 12 to 26 weeks delay was 7.6% 
and 1.7% experienced more than 26 weeks delay. 
Table 3 is a cross tabulation of ethnicity and time since diagnosis or delay among 
119 lymphoma patients considered for bone marrow transplantation. Table 3 indicates 
the type of delay experienced by the five ethnic groups. 
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Table 3 
Ethnicity by Delay 
Variable Time since diagnosis to treatment 
Less than 12 weeks More than 12 weeks Total 
# % # % # % 
Ethnicity 
Black 24 20.2 3 2.5 27 22.7 
White 71 59.7 7 5.9 78 65.5 
Hispanic 5 4.2 0 0.0 5 4.2 
Asian 1 .8 0 0.0 1 .8 
Other 7 5.9 1 .8 8 6.7 
Total 108 90.8 11 9.2 119 100.0 
X2= -831 df = 4 p = .934 
As shown in Table 3, close to six percent (5.9 %) of lymphoma patients who 
experienced more than 12 weeks delay were white while (2.5%) were black. There were 
no Hispanic or Asian patients who experienced more than 12 weeks delay. 
The chi-square test was conducted to determine if there was a statistically 
significant relationship between ethnicity and delay. Chi-square results indicate there is 
no statistically significant relationship between ethnicity and delay at the .05 probability 
level. 
Table 4 is a cross tabulation of marital status and delay among 119 lymphoma 
patients considered for bone marrow transplantation. Table 4 indicates marital status and 
the type of delay experienced by these lymphoma patients. 
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Table 4 
Marital Status by Delay 
Variable Time since diagnosis to treatment 
Less than 12 weeks More than 12 weeks 




Married 69 58.0 7 5.9 76 63.9 
Never married 18 15.1 3 17.6 21 17.6 
Widowed 4 3.4 0 0.0 4 3.4 
Divorced 12 10.1 1 .8 13 10.9 
Separated 2 1.7 0 0.0 2 1.7 
Domestic partner 3 2.5 0 0.0 3 2.5 
Total 108 90.8 11 9.2 119 100.0 
X2= 1.590 df = 5 p =.902 
As shown in Table 4, close to six percent (5.9%) of married lymphoma patients 
experience more than 12 weeks delay. Lymphoma patients who were never married and 
experienced more than 12 weeks delay was (17.6%) and patients who indicated they were 
divorced and experienced more than 12 weeks delay was (.8%). Those patients who 
indicated they were widowed, separated, or reported having domestic partners had no 
results of delay more than 12 weeks. 
The chi-square test was conducted to determine if there was a statistically 
significant relationship between marital status and delay. Chi-square results indicate 
there is no statistically significant relationship between marital status and delay at the .05 
probability level. 
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In the study, having children may be a source of emotional support or positive 
motivation for the patient. This type of support can best be explained utilizing the 
following measures: 1) no children; 2) children under age 18; and 3) children over 
age 18. 
Table 5 is a cross tabulation of children as a source of support and delay among 
119 lymphoma patients considered for bone marrow transplantation. Table 5 indicates 
the type of delay experienced by lymphoma patients with or without children. 
Table 5 
Children by Delay 
Variable Time since diagnosis to treatment 
Less than 12 weeks More than 12 weeks Total 
# % # % # % 
Children 
None 16 13.4 
Under 18 years 33 27.7 
Over 18 years 59 49.6 
Total 108 90.8 
X2 = .741 df= 
2 1.7 18 15.1 
2 1.7 35 29.4 
7 5.9 66 55.5 
11 9.2 119 100.0 
p = .691 
As shown in Table 5, (5.9%) of lymphoma patients with children over 18 years of 
age experienced more than 12 weeks delay. Those patients who indicated they had no 
children or had children under the age of 18 years of age had the same results of (1.7%) 
for delay more than 12 weeks. 
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The chi-square test was conducted to determine if there was a statistically 
significant relationship between children as a source of social support and delay. 
Chi-square results indicate there is no statistically significant relationship between 
children as a source of support and delay at the .05 probability level. 
Table 6 is a cross tabulation of the major source of emotional support and delay 
among 119 lymphoma patients considered for bone marrow transplantation. Table 6 
indicates the type of delay experienced by lymphoma patients with regard to 1 ) family, 
2) extended family, and 3) friends. This result served as indication of the first selection 
of emotional support reported by the patient to the social worker. 
Table 6 
Major source of emotional support by Delay 
Variable Time since diagnosis to treatment 
Less than 12 weeks More than 12 weeks Total 
# % # % # % 
Emotional Support 
Family 91 77.8 8 6.8 99 84.6 
Extended family 8 6.8 2 1.7 10 8.5 
Friends 7 6.0 1 .9 8 6.8 
Total 106 90.6 11 9.4 117 100.0 
Note: 2 missing responses 
X2= 1-612 df = 2 p = .447 
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As shown in Table 6, (77.8%) of lymphoma patients who experienced less than 
12 weeks delay indicated family as their major source of support. Patients who indicated 
having extended family as their major source of support and having experienced less than 
12 weeks delay was (6.8%). The majority of the patients who experienced more than 12 
weeks delay and indicated family as their major source of support was (6.8%). 
The chi-square test was conducted to determine if there was a statistically 
significant relationship between major source of emotional support and delay. 
Chi-square results indicate there is no statistically significant relationship between 
major source of emotional support and delay at the .05 probability level. 
Table 7 is a cross tabulation of the second major source of emotional support and 
delay among 119 lymphoma patients considered for bone marrow transplantation. Table 
7 indicates the type of delay experienced by lymphoma patients with regard to 1 ) family, 
2) extended family, and 3) friends. This result served as indication of the second or 
‘next- in-line’ selection of emotional support reported by the patient to the social worker. 
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Table 7 
Second major source of emotional support by Delay 
Variable Time since diagnosis to treatment 
Less than 12 weeks More than 12 weeks Total 
# % # % # % 
Second major source 
of emotional support 
Family 6 7.1 2 2.4 8 9.5 
Extended family 21 25.0 3 3.6 24 28.6 
Friends 46 54.8 2 2.4 48 57.1 
Other 2 2.4 2 2.4 4 4.8 
Total 75 89.3 9 10.7 84 100.0 
Note: 35 missing responses 
X2 = 10.391 df = 3 p = .016 
As shown in Table 7, (54.8%) of lymphoma patients who experienced less than 
12 weeks delay indicated friends as their second major source of support. Patients who 
indicated having extended family as their second major source of support and having 
experienced less than 12 weeks delay was (25.0%). The majority of the patients who 
experienced more than 12 weeks delay and indicated extended family as their second 
major source of support was (3.6%). 
The chi-square test was conducted to determine if there was a statistically 
significant relationship between the second major source of emotional support and delay. 
Chi-square results indicate there is a statistically significant relationship between the 
second major source of emotional support and delay at the .05 probability level. 
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Church/spiritual support can best be explained utilizing the following measures: 
1) personal prayer; 2) church attendance; and 3) visits with the clergy. Table 8 is a cross 
tabulation of church/spiritual support as a source of emotional support and delay among 
119 lymphoma patients considered for bone marrow transplantation. 
Table 8 
Support from church/spiritual by Delay 
Variable Time since diagnosis to treatment 
Less than 12 weeks More than 12 weeks Total 
# % # % # % 
Church/Spiritual 
None 18 15.1 2 1.7 20 16.8 
Personal prayer 51 42.9 5 4.2 56 47.1 
Church attendance 37 31.1 4 3.4 41 34.5 
Visit with clergy 2 1.7 0 0.0 2 1.7 
Total 108 90.8 11 9.2 119 100.0 
= .237 df = 3 p = .971 
As shown in Table 8, (42.9%) of lymphoma patients who experienced less than 
12 weeks delay indicated personal prayer as a source of support. Patients who indicated 
church attendance as a source of support and having experienced less than 12 weeks 
delay was (31.1%). The majority of the patients who experienced more than 12 weeks 
delay and indicated personal prayer as a source of support was (4.2%). 
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The chi-square test was conducted to determine if there was a statistically 
significant relationship between the church/spiritual support as a source of emotional 
support and delay. Chi-square results indicate there is no statistically significant 
relationship between church/spiritual support and delay at the .05 probability level. 
Table 9 is a cross tabulation of clinician support as a source of informational 
support and delay among 119 lymphoma patients considered for bone marrow 
transplantation. Informational support can best be explained utilizing the following 
measures for clinician support: 1) nurse; 2) social worker; and 3) physician. 
Table 9 
Support from clinician by Delay 
Variable Time since diagnosis to treatment 
Less than 12 weeks More than 12 weeks Total 
# % # % # % 
Clinician 
Nurse 86 72.3 
Social worker 9 7.6 
Physician 13 10.9 
Total 108 90.8 
x2 = .366 df=2 
8 6.7 94 79.0 
1 .8 10 8.4 
2 1.7 15 12.6 
11 9.2 119 100.0 
p = .833 
Table 9 indicates that (72.3%) of lymphoma patients who experienced less than 
12 weeks delay received informational support from a nurse. Patients who indicated 
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having received support from a social worker and having experienced less than 12 weeks 
delay was (7.6%). Patients who experienced more than 12 weeks delay and indicated 
having received support from a physician was (10.9%). 
The chi-square test was conducted to determine if there was a statistically 
significant relationship between clinician support as a source of informational support 
and delay. Chi-square results indicate there is no statistically significant relationship 
between clinician support and delay at the .05 probability level. 
Table 10 is a cross tabulation of formal peer support as a source of informational 
support and delay among 119 lymphoma patients considered for bone marrow 
transplantation. Formal peer support can best be indicated utilizing the following 
measures: 1) No (no support); and 2) Yes (received support). 
Table 10 
Formal Peer Support by Delay 
Variable Time since diagnosis to treatment 
Less than 12 weeks More than 12 weeks Total 
# % # % # % 
Formal peer support 
No 107 89.9 10 8.4 117 98.3 
Yes 1 .8 1 .8 2 1.7 
Total 108 90.8 11 9.2 119 100.0 
X2 = 4.028 df= 1 p = .045 
95 
Table 10 indicates that (.8%) of lymphoma patients who experienced less than 12 
weeks delay received formal peer support. Patients who indicated having received 
support from a formal peer and having experienced more than 12 weeks delay was (.8%). 
The chi-square test was conducted to determine if there was a statistically 
significant relationship between formal peer support as a source of informational support 
and delay. Chi-square results indicate there is a statistically significant relationship 
between formal peer support and delay at the .05 probability level. 
Table 11 is a cross tabulation of formal group support as a source of 
informational support and delay among 119 lymphoma patients considered for bone 
marrow transplantation. Formal group support can best be indicated utilizing the 
following measures: 1) No (no support); and 2) Yes (received support). 
Table 11 
Formal Group Support by Delay 
Variable Time since diagnosis to treatment 
Less than 12 weeks More than 12 weeks Total 
# % # % # % 
Group support 
No 101 84.9 10 8.4 111 93.3 
Yes 7 5.9 1 .8 8 6.7 
Total 108 90.8 11 9.2 119 100.0 
X2 = .108 df= 1 p = .742 
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Table 11 indicates that (5.9%) of lymphoma patients who experienced less than 
12 weeks delay received formal group support. Patients who indicated having received 
support from group participation and having experienced more than 12 weeks delay was 
(.8%). 
The chi-square test was conducted to determine if there was a statistically 
significant relationship between formal group support as a source of informational 
support and delay. Chi-square results indicate there is no statistically significant 
relationship between formal group support and delay at the .05 probability level. 
Table 12 is a cross tabulation of employment status as a source of instrumental 
support and delay among 119 lymphoma patients considered for bone marrow 
transplantation. Employment status can best be explained utilizing the following 
measures: 1) employed; 2) unemployed; 3) self-employed; 4) retired; 5) homemaker; 
and 6) disabled. 
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Table 12 
Employment status by Delay 
Variable Time since diagnosis to treatment 
Less than 12 weeks More than 12 weeks Total 
# % # % # % 
Employment status 
Employed 46 38.7 5 4.2 51 42.9 
Unemployed 23 19.3 3 2.5 26 21.8 
Self-employed 3 2.5 0 0.0 3 2.5 
Retired 15 12.6 1 .8 16 13.4 
Homemaker 3 2.5 0 0.0 3 2.5 
Disabled 18 15.1 2 1.7 20 16.8 
Total 108 90.8 11 9.2 119 100.0 
t = .978 df = 5 p = .964 
Table 12 indicates that (38.7%) of lymphoma patients who experienced less than 
12 weeks delay were employed and (19.3%) were unemployed. Patients who indicated 
having employment but experienced more than 12 weeks delay was (4.2%) and those 
unemployed was (2.5%). 
The chi-square test was conducted to determine if there was a statistically 
significant relationship between employment status as a source of instrumental support 
and delay. Chi-square results indicate there is no statistically significant relationship 
between employment status and delay at the .05 probability level. 
Table 13 is a cross tabulation of health insurance status as a source of 
instrumental support and delay among 119 lymphoma patients considered for bone 
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marrow transplantation. Health insurance status can best be explained utilizing the 
following measures: 1) none; 2) public insurance; and 3) private insurance. 
Table 13 
Health insurance status by Delay 
Variable Time since diagnosis to treatment 
Less than 12 weeks More than 12 weeks 




None 4 3.4 1 .8 5 4.2 
Public insurance 25 21.0 3 2.5 28 23.5 
Private insurance 79 66.4 7 5.9 86 72.3 
Total 108 90.8 11 9.2 119 100.0 
X2 = .887 df = 2 p = .642 
Table 13 indicates that a majority (66.4%) of lymphoma patients who experienced 
less than 12 weeks delay had private insurance. Patients who indicated having no 
insurance and experienced more than 12 weeks delay was (.8%). 
The chi-square test was conducted to determine if there was a statistically 
significant relationship between health insurance status as a source of instrumental 
support and delay. Chi-square results indicate there is no statistically significant 
relationship between health insurance status and delay at the .05 probability level. 
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Table 14 is a cross tabulation of living arrangement as a source of instrumental 
support and delay among 119 lymphoma patients considered for bone marrow 
transplantation. Living arrangement can best be explained utilizing the following 
measures: 1 ) live alone; and 2) live with others. 
Table 14 
Living arrangement by Delay 
Variable Time since diagnosis to treatment 
Less than 12 weeks More than 12 weeks Total 
# % # % # % 
Living arrangement 
Live alone 10 8.4 2 1.7 12 10.1 
Live with others 98 82.4 9 7.6 107 89.9 
Total 108 90.8 11 9.2 119 100.0 
t = -877 df= 1 p = .349 
Table 14 indicates that a majority (82.4%) of lymphoma patients who experienced 
less than 12 weeks delay lived with others. Patients who indicated living alone and 
experienced more than 12 weeks delay was (1.7%). 
The chi-square test was conducted to determine if there was a statistically 
significant relationship between living arrangement as a source of instrumental support 
and delay. Chi-square results indicate there is no statistically significant relationship 
between living arrangement and delay at the .05 probability level. 
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Results of Hypothesis Testing 
Binary forward logistic regression was conducted to determine which 
independent variables (age, gender, ethnicity, employment status, insurance status, 
marital status, and children) were predictors of treatment delay greater than 60 days and 
treatment delay greater than 90 days. Separate logistic regressions were run on each 
dependent variable for treatment delay. The average number of days from initial 
diagnosis to initial treatment was 52 days (M= 52.05, S = 134.73). The median number 
of days from initial diagnosis to initial treatment was 32 days. 
Hypothesis la: Demographic characteristics (age, gender, ethnicity, 
employment status, insurance status, marital status, and 
children) predict delay of treatment greater than 60 days. 
Logistic regressions were conducted to determine which independent variables 
(age, gender, ethnicity, employment status, insurance status, marital status, and children) 
were predictors of treatment delay greater than 60 days. Data screening led to the 
elimination of six outliers. Regression results indicated the overall model fit of one 
predictor (gender) was statistically reliable in distinguishing between the presence or 
absence of treatment delay greater than 60 days (-2 Log Likelihood=123.183, 
y2(l )=4.264, p<.05). The model correctly classified 77.3% of the cases. Regression 
coefficients are presented in Table 15. 
Wald statistics indicated that gender significantly predicted the presence of 
treatment delay greater than 60 days. Odds ratios for this variable indicated change in 
the likelihood of having treatment delay greater than 60 days when the predictors 
increase by 1. 
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A cross-tabulation measurement revealed that a higher percentage of males 
(29.4%) experienced treatment delay greater than 60 days than females (13.7%). The phi 
(O) statistical measurement indicated a weak relationship (4> = -.185) between the two 
variables. 
Table 15 
Regression coefficients for treatment delay greater than 60 days - demo 
B Wald df P Odds Ratio 
Gender (1) .963 3.921 1 .048 2.619 
Hypothesis lb: Demographic characteristics (age, gender, ethnicity, 
employment status, insurance status, marital status, and 
children) predict delay of treatment greater than 90 days. 
Logistic regressions were conducted to determine which independent variables 
(age, gender, ethnicity, employment status, insurance status, marital status, and children) 
were predictors of treatment delay greater than 90 days. Data screening led to the 
elimination of seven outliers. Regression results indicated that none of the predictors fit 
the overall model. Regression coefficients of variables not in the equation are presented 
in Table 16. 
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Table 16 
Regression coefficients of variables not in the equation for delay greater than 
90 days - demo 
Score df P 
Age group (1) 1.339 1 .247 
Age group (2) .106 1 .745 
Age group (3) .218 1 .640 
Gender (1) .737 1 .391 
Ethnicity (1) .333 1 .564 
Ethnicity (2) .149 1 .700 
Ethnicity (3) .479 1 .489 
Ethnicity (4) .093 1 .761 
Employment Status (1) .227 1 .633 
Employment Status (2) .425 1 .515 
Employment Status (3) .282 1 .595 
Employment Status (4) .111 1 .739 
Employment Status (5) .282 1 .595 
Insurance Status( 1 ) .912 1 .340 
Insurance Status(2) .254 1 .614 
Marital Status (1) .071 1 .790 
Marital Status (2) 1.146 1 .284 
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Table 16 (continued) 
Score df P 
Marital Status (3) .380 1 .538 
Marital Status (4) .010 1 .922 
Marital Status (5) .187 1 .666 
Child (1) .202 1 .653 
Child (2) .466 1 .495 
Hypothesis lc: Social Support (having a major source of support, receiving 
support from church/spiritual, receiving support from a 
clinician, having formal peer support, and having formal 
group support) predicts delay of treatment greater than 60 
days. 
Logistic regressions were conducted to determine which independent variables 
(having a major source of support, receiving support from church-spiritual, receiving 
support from a clinician, having formal peer support, and having formal group support) 
were predictors of treatment delay greater than 60 days. Data screening led to the 
elimination of four outliers. Regression results indicated the overall model fit of one 
predictor (receiving support from a clinician) was statistically reliable in distinguishing 
between the presence or absence of treatment delay greater than 60 days 
(-2 Log Likelihood = 115.556, x2(l) = 11.891, p<01). The model correctly classified 
79.8% of the cases. Regression coefficients are presented in Table 17. 
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Wald statistics indicated that receiving support from a clinician significantly 
predicted the presence of treatment delay greater than 60 days. Odds ratios for this 
variable indicated change in the likelihood of having delay greater than 60 days when the 
predictors decrease by 1. 
A cross-tabulation measurement revealed patients who received support from a 
social worker had lower percentages of delay (10%) than patients who received support 
from a nurse (18.1%) or a physician (60.0%). The phi (O) statistical measurement 
indicated a moderate relationship (<E> = .342) between the two variables. 
Table 17 
Regression coefficients of treatment delay greater than 60 days - social support 
B Wald df P Odds Ratio 
Clinician support ( 1 ) -1.916 10.502 1 .001 .147 
Clinician support (2) -2.603 4.977 1 mi .074 
Hypothesis Id: Social Support (having a major source of support, receiving 
support from church-spiritual, receiving support from a 
clinician, having formal peer support, and having formal 
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group support) predicts delay of treatment greater than 90 
days. 
Logistic regressions were conducted to determine which independent variables 
(having a major source of support, receiving support from church-spiritual, receiving 
support from a clinician, having formal peer support, and having formal group support) 
were predictors of treatment delay greater than 90 days. Data screening led to the 
elimination of four outliers. Regression results indicated the overall model fit of one 
predictor (having formal peer support) was statistically reliable in distinguishing between 
the presence or absence of treatment delay greater than 90 days (-2 Log Likelihood= 
66.231 x2( 1 )= 2.435, p=.l 19). The model correctly classified 91.6% of the cases. 
Regression coefficients are presented in Table 18. 
Wald statistics indicated that having formal peer support did not significantly 
predict the presence of treatment delay greater than 90 days. Odds ratios for this variable 
indicated change in the likelihood of having delay greater than 90 days when the 
predictors decrease by 1. 
Table 18 
Regression coefficients for treatment delay greater than 90 days - social support 
B Wald df P Odds Ratio 
Peer support (1) -2.485 2.912 1 .088 .083 
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Hypothesis le: Demographic characteristics (age, gender, ethnicity, 
employment status, insurance status, marital status, and 
children) predict delay of BMT greater than 24 weeks. 
Logistic regressions were conducted to determine which independent variables 
(age, gender, ethnicity, employment status, insurance status, marital status, and children) 
were predictors of BMT delay greater than 24 weeks. Data screening led to the 
elimination of seven outliers. Regression results indicated that none of the predictors fit 
the overall model. Regression coefficients of variables not in the equation are presented 
in Table 19. 
Table 19 
Regression coefficients of variables not in the equation for delay of BMT greater than 
24 weeks - demo 
Score df P 
Age group (1) .000 1 .985 
Age group (2) 5.024 1 .025 
Age group (3) 4.330 1 .037 
Gender (1) .111 1 .739 
Ethnicity (1) 1.687 1 .194 
Ethnicity (2) .116 1 .734 
Ethnicity (3) 1.179 1 .278 
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Table 19 (continued) 
Score df P 
Ethnicity (4) .285 1 .594 
Employment Status (1) .916 1 .339 
Employment Status (2) 2.162 1 .141 
Employment Status (3) .576 1 .448 
Employment Status (4) .026 1 .873 
Employment Status (5) .576 1 .448 
Insurance Status(l) 1.916 1 .166 
Insurance Status(2) .440 1 .507 
Marital Status (1) 3.365 1 .067 
Marital Status (2) 1.351 1 .245 
Marital Status (3) .874 1 .350 
Marital Status (4) 4.016 1 .045 
Marital Status (5) .936 1 .333 
Child (1) 1.821 1 All 
Child (2) .082 1 .114 
Hypothesis If: Diagnosis and stage of disease (relapsed Hodkin’s, relapsed 
follicular, relapsed diffuse large B-cell, stages I, II, III, and IV) 
predicts delay of bone marrow transplantation treatment. 
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Logistic regressions were conducted to determine which independent variables 
(relapsed Hodkin’s, relapsed follicular, relapsed diffuse large B-cell, stages I, II, III, and 
IV) were predictors of delay for bone marrow transplantation treatment. Data screening 
led to the elimination of four outliers. Regression results indicated the overall model fit 
of three predictors (relapsed Hodgkin’s, relapsed follicular, relapsed diffuse large B-cell) 
were statistically reliable in distinguishing between the presence or absence of bone 
marrow transplantation treatment delay (-2 Log Likelihood= 87.301, x2( 1 )= 8.545, 
p<.05). The model correctly classified 78% of the cases. Regression coefficients are 
presented in Table 20. 
Wald statistics indicated that diagnosis (3) (relapsed diffuse large B-cell) 
significantly predicted treatment delay. Odds ratio for this variable indicated change in 
the likelihood of having bone marrow transplantation treatment delay when the predictor 
decreases by 1. 
A cross-tabulation measurement revealed patients who were diagnosed with 
relapsed diffuse large B-cell lymphoma received bone marrow transplantation treatment 
within less than 24 weeks (89.2%). The phi (<ï>) statistical measurement indicated a 
moderate relationship (<I> = .311) between the variables. 
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Table 20 
Regression coefficients for delay of BMT greater than 24 weeks - diagnosis 
B Wald df P Odds Ratio 
Diagnosis (1) -.811 1.578 1 .209 .444 
Diagnosis (2) -1.792 2.433 1 .119 .167 
Diagnosis (3) -1.823 6.997 1 .008 .162 
Hypothesis lg: Social Support (having a major source of support, receiving 
support from church-spiritual, receiving support from a 
health professional, having formal peer support arranged, 
and having formal group support arranged) predicts delay 
of BMT greater than 24 weeks. 
Data screening led to the elimination of five outliers. Regression results indicated 
that none of the predictors fit the overall model. Regression coefficients of variables not 
in the equation are presented in Table 21. 
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Table 21 
Regression coefficients of variables not in the equation for delay greater than 
90 days - social support 
Score df P 
Major Source of Support ( 1 ) .576 1 .448 
Major Source of Support (2) 2.728 1 .099 
Major Source of Support (3) 6.567 1 .010 
Church-Spiritual Support (1) 1.821 1 .177 
Church-Spiritual Support (2) .617 1 .432 
Church-Spiritual Support (3) 2.934 1 .087 
Health Professional Support ( 1 ) 3.094 1 .079 
Health Professional Support (2) 4.016 1 .045 
Formal Peer Support (1) 3.589 1 .058 
Formal Group Support (1) 1.490 1 .222 
Hypothesis lh: Days of Delay predicts delay of bone marrow 
transplantation treatment greater than 60 days. 
Logistic regressions were conducted to determine which independent variables 
were predictors of treatment delay greater than 60 days. Data screening led to the 
elimination of four outliers. Regression results indicated the overall model fit of one 
predictor was statistically reliable in distinguishing between the presence or absence of 
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treatment delay greater than 60 days (-2 Log Likelihood= 84.627, %2(1)= 11.220, p<.01). 
The model correctly classified 82.4% of the cases. Regression coefficients are presented 
in Table 22. 
Wald statistics indicated that receiving bone marrow transplantation significantly 
predicted the presence of treatment delay greater than 60 days. Odds ratios for this 
variable indicated change in the likelihood of having delay greater than 60 days when the 
predictors decrease by 1. 
Table 22 
Regression coefficients for delay of BMT greater than 24 weeks - diagnosis 
B Wald df P Odds Ratio 
Delay > 90 Days ( 1 ) -3.150 7.746 1 .005 .043 
Hypothesis li: Demographic and clinical characteristics (age, gender, 
ethnicity, employment status, health insurance status, 
marital status, children, diagnosis, and stage of disease) 
predict receipt of bone marrow transplantation. 
Logistic regressions were conducted to determine which independent variables 
(age, gender, ethnicity, employment status, health insurance status, marital status, 
children, diagnosis, and stage of disease) were predictors of receipt of bone marrow 
transplantation. Data screening led to the elimination of 9 outliers. Regression results 
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indicated that none of the predictors fit the overall model. Regression coefficients of 
variables not in the equation are presented in Table 23. 
Table 23 
Regression coefficients of variables not in the equation for receipt of bone marrow 
transplantation 
Score df P 
Age group (1) .425 1 .514 
Age group (2) 1.699 1 .192 
Age group (3) .888 1 .346 
Gender (1) .191 1 .662 
Ethnicity (1) 1.866 1 .172 
Ethnicity (2) 1.145 1 .285 
Ethnicity (3) .036 1 .849 
Ethnicity (4) .310 1 .577 
Employment Status (1) 6.865 1 .009 
Employment Status (2) 2.272 1 .132 
Employment Status (3) .164 1 .685 
Employment Status (4) 2.005 1 .157 
Employment Status (5) .164 1 .685 
Insurance Status(l) .036 1 .849 
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Table 23 (continued) 
Score df P 
Insurance Status(2) 3.021 1 .082 
Marital Status (1) 1.681 1 .195 
Marital Status (2) .360 1 .548 
Marital Status (3) .005 1 .944 
Marital Status (4) 1.809 1 .179 
Marital Status (5) .626 1 .429 
Child (1) .020 1 .403 
Child (2) .701 1 .679 
Diagnosis (1) .053 1 .819 
Diagnosis (2) .016 1 .899 
Diagnosis (3) .763 1 .382 
Stage of disease (1) .036 1 .849 
Stage of disease (2) .756 1 .385 
Stage of disease (3) 1.742 1 .187 
Stage of disease (4) 2.861 1 .091 
CHAPTER V 
CONCLUSIONS AND RECOMMENDATIONS 
The research study was designed to answer the question concerning the influence 
social support (emotional, informational, and instrumental) has on the amount of time 
between receiving a lymphoma diagnosis and receiving initial recommended treatment. 
The conclusions and recommendations of the research findings are presented in 
this chapter. Recommendations are proposed for future discussions for social workers, 
health care practitioners and administrators, and policy makers. The research question is 
presented to summarize the significant findings of interest. 
Research Question: Does having access to emotional, informational, and/or 
instrumental support decrease the amount of time between 
receiving a lymphoma diagnosis and receiving initial 
recommended treatment? 
In order to determine if social support was influential in treatment delay, the types 
of social support (emotional, informational, and instrumental) were identified and 
analyzed. Emotional support was indicated by the following factors: a major source of 
support of family, extended family, friends or others; marital status; church/spiritual; and 
children. Informational support was indicated by the following factors: clinician (nurse, 
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social worker, physician); formal peer services; and formal group services. Instrumental 
support was indicated by employment status, health insurance status, and living 
arrangement. 
Of the 119 patients who received bone marrow transplantation social work 
assessments, a majority of patients (63.9%) were married, had adult children (55.5%), 
relied on personal prayer (47.1%), identified their family (83.2%) as their major source 
of emotional support. The results or informational support showed a majority (79%) 
received support from nurses, only (1.7%) received formal peer support, and (6.7%) 
received formal group support. The results on instrumental support showed a majority of 
patients (42.9%) were employed, (72.3%) had private insurance, and (89.9%) were living 
with other people. All patients had daily living needs (access to food, shelter, and 
transportation) that were met. Although some patients had gone through clinical trial 
evaluation, there was no clinical trial participation. 
In order to determine if social support was influential in treatment delay, the 
amount of time between receiving a lymphoma diagnosis and receiving initial 
recommended treatment was analyzed. A majority of patients experienced typical delay, 
which was less than 12 weeks (90.8%). Those who experienced significant delay were 
(7.6%) for 12 to 26 weeks delay and (1.7%) for more than 26 weeks delay. 
Additionally, the amount of time between receiving a lymphoma diagnosis and 
receiving a bone marrow transplantation was also analyzed. Of the 119 patients who 
received social work assessments, 91 (76.5%) actually received bone marrow 
transplantation. 
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The bone marrow transplantation social work assessments collected on 119 
patients provided useful information on perceived and/or received social support needs of 
relapsed lymphoma patients considered for transplantation. All patients had prior 
histories of lymphoma disease, had received standard treatment, including, for some 
patients, prior bone marrow transplantation. They presented with a range of from no 
symptoms to a combination of the following symptoms: swollen lymph nodes or lumps, 
low energy or fatigue, pain, stomach pain, bruising, night sweats and itching. If there 
were no symptoms, diagnosis was discovered through CT or PET scans or tests given for 
other concerns. 
The patients were typically seen at the clinic for a ‘New Patient Consult’ and 
given the diagnosis. Most were accompanied by a family member or friend. They were 
immediately assigned to a nurse care coordinator, who explained the mechanics of 
getting bone marrow transplantation; helped coordinate with different treatment services; 
to each new patient, provided a calendar for treatment appointments; and provided 
continual follow/up assistance. 
Most patients admitted being shocked about their relapse diagnosis. Once the 
diagnosis for the relapsed lymphoma (date of diagnosis used in this analysis) was 
confirmed, most of the 119 patients received treatment with little to no delay (typical 
delay). Standard care consisted of prompt treatment that prepared the patient for 
transplantation. This treatment is referred to as ICE or R-ICE, which is a combination of 
chemotherapy drugs. Several cycles of this treatment may be administered. Stem cells 
are collected and stored. Some patients were treated on outpatient status and others were 
admitted for inpatient care. 
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The next scheduled appointment date (initial treatment date used in this analysis) 
occurs to provide a treatment plan to the patient, conduct the social work assessment, and 
administer continued care. 
Social work assessments were most often requested by the oncologist. During the 
assessment, information is exchanged and collected. The social workers often provided 
psychosocial counseling at this session. One interesting question that the social worker 
typically asked was ‘What are your long term expectations?’ The most repeated answer 
was ‘to live a normal life again.’ The patient was encouraged to put together a 
caregiving team. Most were able to do so. A resource packet was given to each patient. 
The following information was included in the packet: a preparing for stem cell 
transplant checklist, fundraising information, an application for assistance through the 
Leukemia / Lymphoma Society, scheduling for Patient and Family Stem Cell Transplant 
Orientation, a flier on bone marrow transplantation support group, and a list of local 
community resources. 
The patient was given post-transplantation suggestions for lodging plans due to 
standard care requirements to reside within 30 minutes of the transplant center for a 
month afterwards. Contact information for the Winn Dixie Hope Lodge and alternative 
lodging information was provided. During this period, the patient must also have a 
caregiver with them at all times. Many of the patients and their families traveled for 
treatment from locations outside of metro Atlanta. They were encouraged to fundraise to 
offset many of the costs. 
The social work assessment session was complete when the social worker had 
explained his/her availability for continued support and provided the patient with contact 
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information. Social workers were contacted by a few patients and social work notes on 
these consultations were included in the hematology notes section of the Emory 
University Healthcare databases. The social worker continued to work with the 
multidisciplinary team throughout patient care. 
Of the 119 lymphoma patients, (5.9 %) of lymphoma patients who experienced 
more than 12 weeks delay were white while (2.5%) were black. There were no 
Hispanic or Asian patients who experienced more than 12 weeks delay. When the 
chi-square statistical test for significance was applied, the null hypothesis was not 
rejected (p = .934) indicating that there was no statistically significant relationship 
between ethnicity and delay at the .05 level of probability (See Table 3). 
Close to six percent (5.9 %) of married patients who experienced more than 12 
weeks delay. Lymphoma patients who were never married and experienced more than 12 
weeks delay was (17.6%) and patients who indicated they were divorced and experienced 
more than 12 weeks delay was (.8%). Those patients who indicated they were widowed, 
separated, or reported having domestic partners had no results of delay more than 12 
weeks. When the chi-square statistical test for significance was applied, the null 
hypothesis was not rejected (p = .902) indicating that there was no statistically significant 
relationship between marital status and delay at the .05 level of probability (See Table 4). 
Lymphoma patients with children over 18 years of age who experienced more 
than 12 weeks delay were (5.9%). Those patients who indicated they had no children or 
had children under the age of 18 years of age had the same results of (1.7%) for delay 
more than 12 weeks. When the chi-square statistical test for significance was applied, 
the null hypothesis was not rejected (p = .691) indicating that there was no statistically 
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significant relationship between having children as a source of support and delay at the 
.05 level of probability (See Table 5). 
Lymphoma patients who experienced less than 12 weeks delay and indicated 
family as their major source of support were (77.8%). Patients who indicated having 
extended family as their major source of support and having experienced less than 12 
weeks delay was (6.8%). The majority of the patients who experienced more than 12 
weeks delay and indicated family as their major source of support were (6.8%). When 
the chi-square statistical test for significance was applied, the null hypothesis was not 
rejected (p = .447) indicating that there was no statistically significant relationship 
between major source of emotional support and delay at the .05 level of probability (See 
Table 6). 
Lymphoma patients who experienced less than 12 weeks delay and indicated 
friends as their second major source of support were (54.8%). Patients who indicated 
having extended family as their second major source of support and having experienced 
less than 12 weeks delay was (25.0%). The majority of the patients who experienced 
more than 12 weeks delay and indicated extended family as their second major source of 
support was (3.6%). When the chi-square statistical test for significance was applied, the 
null hypothesis was rejected (p = .016) indicating that there is a statistically significant 
relationship between the second major source of emotional support and delay at the .05 
level of probability (See Table 7). 
Lymphoma patients who experienced less than 12 weeks delay and indicated 
personal prayer as a source of support were (42.9%). Patients who indicated church 
attendance as a source of support and having experienced less than 12 weeks delay was 
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(31.1 %). The majority of the patients who experienced more than 12 weeks delay and 
indicated personal prayer as a source of support were (4.2%). When the chi-square 
statistical test for significance was applied, the null hypothesis was not rejected 
(p = .971) indicating that there was no statistically significant relationship between 
church/spiritual support and delay at the .05 level of probability (See Table 8). 
Lymphoma patients who experienced less than 12 weeks delay and received 
informational support from a nurse were (72.3%). Patients who indicated having 
received support from a social worker and having experienced less than 12 weeks delay 
was (7.6%). Patients who experienced more than 12 weeks delay and indicated having 
received support from a physician was (10.9%). When the chi-square statistical test for 
significance was applied, the null hypothesis was not rejected (p = .833) indicating that 
there was no statistically significant relationship between clinician support and delay at 
the .05 level of probability (See Table 9). 
Lymphoma patients who experienced less than 12 weeks delay and received 
formal peer support were (.8%). Patients who indicated having received support from a 
formal peer and having experienced more than 12 weeks delay was (.8%). When the 
chi-square statistical test for significance was applied, the null hypothesis was rejected 
(p = .045) indicating that there is a statistically significant relationship between formal 
peer support and delay at the .05 level of probability (See Table 10). 
Lymphoma patients who experienced less than 12 weeks delay and received 
formal group support were (5.9%). Patients who indicated having received support from 
group participation and having experienced more than 12 weeks delay was (.8%). When 
the chi-square statistical test for significance was applied, the null hypothesis was not 
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rejected (p = .742) indicating that there was no statistically significant relationship 
between formal group support and delay at the .05 level of probability (See Table 11). 
Lymphoma patients who experienced less than 12 weeks delay and were 
employed were (38.7%) and (19.3%) were unemployed. Patients who indicated having 
employment but experienced more than 12 weeks delay was (4.2%) and those 
unemployed was (2.5%). When the chi-square statistical test for significance was 
applied, the null hypothesis was not rejected (p = .964) indicating that there was no 
statistically significant relationship between employment status and delay at the .05 level 
of probability (See Table 12). 
A majority of lymphoma patients who experienced less than 12 weeks delay and 
had private insurance were (66.4%). Patients who indicated having no insurance and 
experienced more than 12 weeks delay was (.8%). When the chi-square statistical test for 
significance was applied, the null hypothesis was not rejected (p = .642) indicating that 
there was no statistically significant relationship between health insurance status and 
delay at the .05 level of probability (See Table 13). 
Lymphoma patients who experienced less than 12 weeks delay and lived with 
others were (82.4%). Patients who indicated living alone and experienced more than 12 
weeks delay was (1.7%). When the chi-square statistical test for significance was applied, 
the null hypothesis was not rejected (p = .349) indicating that there was no statistically 
significant relationship between living arrangement and delay at the .05 level of 
probability (See Table 14). 
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As indicated in Table 15, a higher percentage of males (29.4%) experienced 
treatment delay greater than 60 days than females (13.7%). There was a weak 
relationship ($ = -.185) between the two variables. 
As indicated in Table 17, patients who received support from a social worker had 
lower percentages of delay (10%) than patients who received support from a nurse 
(18.1%) or a physician (60.0%). There was a moderate relationship ($ = .342) between 
the variables. 
As indicated in Table 20, patients who were diagnosed with relapsed diffuse large 
B-cell lymphoma received bone marrow transplantation treatment within less than 24 
weeks (89.2%). There was a moderate relationship ($ = .311) between the variables. 
In sum, with the information collected from the 119 social work assessments, the 
expectation was that most factors of social support would significantly influence delay of 
treatment. In the study, gender, clinician support, and delay in bone marrow 
transplantation indicated significance. The majority of the patients represented in the 
sample appeared to have strong social support systems in place, exemplary profiles for 
the selection criterion of technologically advanced treatment methods such as bone 
marrow transplantation. Aside from the 119 available social work assessments used in 
this study, there exists a list of over 200 lymphoma patients possibly in need of similar 
treatment who did not receive social work assessments. This list dates back to 1996 and 
social work assessments for bone marrow transplantation began to appear in 2002. Only 
26 of these 200 patients were referred from 2002 to present. So the majority were 
patients prior to 2002 and, according to practices at that time, would not have received 
social work assessments. The collection of vital patient data, including demographic 
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information such as ethnicity, was incomplete. The researcher questions if this is the 
underserved group, possibly equipped with less than the required social support system, 
that this study might have examined. What happened to patients from this particular list? 
Did they receive treatment or are they experiencing patient, provider, or administrative 
delay? 
Based on the literature review, social support does assist in neutralizing the 
effects of distress and lymphoma patients often experience some level of distress at 
diagnosis. The results of this study are consistent with emerging studies such as Frick’s 
et al. (2005), who did not find any association between positive social support and 
survival among patients undergoing autologous peripheral blood stem cell transplantation 
but did obtain a relationship between negative or problematic social support and poor 
survival chances following transplantation. 
In the overall results specific to this study, significant differences in ethnicity, 
social support, and treatment delay were not found. The patients represented in this 
sample, including African-American patients, received quality cancer care. To address 
health disparity concerns, the information gathered from this study on the social support 
needs of these lymphoma patients provides a meaningful profile for social support that 
will be helpful in securing quality care for African-America lymphoma and/or bone 
marrow transplantation patients. 
Future studies should be conducted to continue to test social support and its 
impact on health outcomes. With this study, the work has been extended. Though not 
enough to make substantial conclusions, the study results were meaningful enough to 
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raise important questions about health-seeking behaviors and the expanding role the 
social work profession must claim in health care provision. 
Recommendations 
Research on social support and survival must continue with a focus on 
lymphoma, as the non-Hodgkin’s lymphoma incidence rate is rapidly increasing. 
Understanding the support needs of African-American cancer patients will help to 
continue to provide quality health care and address the issues of health disparity. Social 
workers are needed to play an even larger role in this endeavor. Patient education on 
how to care for self and family, should chronic illness occur, can be conducted on the 
individual and community level. As a result of the findings of this study, the researcher 
is recommending the following: 
1. Social workers should utilize their skills as counselor, educator, and 
advocate, on the individual and community level, to help facilitate greater 
access to health care resources. 
2. More research conducted by social workers should continue, in order to 
identify and locate the underserved population and provide data on the 
underserved population. 
3. The number of social work staff in health care settings should increase. 
4. Obtain social work assessments for all lymphoma patients. 
APPENDIX A 
Patient Support Index 
Section I: Demographic and Patient Information 
1. Age group: 1) 18-30 2) 31-50 3) 51-70 4) Over 70 
2. Gender l) Male 2) Female 
3. Ethnicity: 1) Black 2) White 3) Hispanic 4) Asian 5) Other 
4. Diagnosis: 1) Relapsed Hodgkin’s 2) Relapsed Follicular 
3) Relapsed Diffuse Large B-Ccll 4) Other NHL 
5. Stage of Disease: 1) Slagel 2) Stage II 3) Stage III 4) Stage IV 
5) Unknown 
5a: Date of Diagnosis  Date of Initial Treatment  (DD - IT = Delay) 
6. Time Since Diagnosis to Initial Treatment: 1) Less than 12 weeks 2) 12 to 26 weeks 
3) More than 26 weeks 
Section Eh Emotional Support 
7. Marital Status: 1)   Married 2) Never Married 3) Widowed 
4) Divorced 5) Separated 6) Domestic Partner 
8. Children: 1) None 2) Under 18Yrs 3) Over 18Yrs 
9. Major source of support: 1) Family 2) Extended Family 3) Friends 
4) Other 
10. Second major source of support: 1) Family 2) Extended Family 3) Friends 
4) Other 
11. Third major source of support: 1) Family 2) Extended Family 3) Friends 
4) _____ Other 
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APPENDIX A (continued) 
12.1 received the most support from church / spiritual : i)  None 2) Personal prayer 
3) Church Attendance 4) Visit with clerev 
13. Which clinician gave me the most support : 1) None 2) Nurse 
3) Social Worker 4) Physician 
14. Formal peer services were arranged: 1) No » 2) Yes 
15. Formal group services were arranged: 1) No 2) Yes 
Section IV: Instrumental Support 
16. Employment status: l) Employed 2) Unemployed 3) Self employed 
4) Retired 5) Homemaker 6) Disabled 
17. I need a olace to live 1) No 2) Yes 
18. I need access to food/prepared meals 1) No 2)  -Yes 
19. I need available transportation 1) No 2) Yes 
20. 1 need childcare assistance 1) No 2) Yes 
21. Health Insurance status: n None 2} Public Insurance 3} Private Insurance 
22. Living arrancement: 1) Live alone 2) Live mtli others 




Dr. Georgiana Bolden 
Office of Sponsored Programs 
dark Atlanta University 
(404) 880-6979 
Re: Study of Social Support and Treatment Delay Among African-American Patients 
Diagnosed with Lymphoma 
Principal Investigator: Roni Glover 
Dear Dr. Bolden: 
Roni Glover is a participant in the ongoing, ERB approved research project on “Assessing 
Treatment Outcomes for Patients with Non-Hodgkin’s Lymphoma” at Emory 
University’s Winship Cancer Institute. Ms. Glover is working directly with the principal 
investigator to examine social support and its influence on treatment delay among 
African-American patients with lymphoma. She has controlled access to existing patient 
data, which is located in the Emory Healthcare Data Center. 
Sincerely, 
Christopher Flowers, MD 
Principal Investigator 
Emory University School of Medicine 




APPENDIX B (continued) 
CLARK ATLANTA UNIVERSITY 
Institutional Review Board 
Office of Sponsored Programs 
January 18, 2006 
Mr. Roni Glover (rmarieg@aoi.com) 
School of Social Work 
Clark Atlanta University 
Atlanta, GA 30314 
RE: Study of Social Support and Treatment Among African-American Patients 
Diagnosed with Hodgkin's/Non Hodgkin's Disease 
Principal Investigator: Roni Glover 
Human Subjects Code Number: HR2006-1-140-1 
Dear Mr. Glover: 
The Human Subjects Committee of the Institutional Review Board (IRB) has reviewed your 
protocol referenced above and approved of it as exempt from full IRB review in accordance 
with 45 CFR 46.106b.2- You may begin your study one week from the date of this notice. 
Protocol Approval Code is HR2006-1-140-1/A 
This approval is valid for one year from the date of this notice. This permit will therefore 
expire on January 17, 2007. Thereafter, continued approval is contingent upon the annual 
submission of a renewal form to this office. Any reaction or problems resulting from this 
investigation should be reported immediately to the IRB, to the Department Chairperson and 
any sponsoring agency. 
If you have any questions, please contact Dr. Georgiana Bolden at the Office of Sponsored 
Programs (404) 880-6979 or Dr. Paul I. Musey, (404) 880-6829. 
Sincerely: 
Chair 
IRB: Human Subjects Committee 
cc. Dr. Margaret Count-Spriggs tmspriggs@cau.edu) 
Office of Sponsored Programs fgbolden@cau.edu'> 
223 James P. Brawley Drive. S.W. * ATLANTA, GA 30314-4391 * (404) 880-8000 
Formed in 1988 by consolidation of Atlanta University, 1865 and Clark College, 1869 
APPENDIX C 
SPSS PROGRAM ANALYSIS 
RON1 GLOVER 
PATIENT SUPPORT INDEX 
STUDY OF SOCIAL SUPPORT AND DELAY OF TREATMENT 
'XTLE 'Study of Social Support and Delay of Treatment*. 
SUBTITLE 'Patient Support Index - Roni Glover* 
’Margaret Counts-Spriggs PhD' 
'Christopher Flowers MD' 






























































will read 1 records from the command file 
Rec start End Format 
1 1 3 F3.0 
1 4 4 FI » 0 
1 5 5 F1.0 
1 6 6 FI. 0 
1 7 7 F1.0 
1 8 8 F1.0 
1 9 9 F1.0 
1 10 10 F1.0 
1 11 11 FI, 0 
1 12 12 FI, 0 
1 13 13 F1.0 
1 14 14 F1.0 
1 15 15 Fl, 0 
1 16 16 FI. 0 
1 17 17 F1.0 
1 18 18 F1.0 
1 19 19 F1.0 
1 20 20 Fl.Q 
1 21 21 F1.0 
1 22 22 F1.0 
1 23 23 F1.0 
1 24 24 F1.0 
1 25 25 F1.0 
1 26 26 F1.0 
1 27 27 F1.0 
1 28 28 F1.0 
VARIABLE LABELS 
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’Q1 Age Group' 
’Q2 Gender * 
’ Q3 Bchnicity’ 
* Q4 Diagnosis* 
'QS Stage of Disease* 
’Q6 Time since diagnosis to initial treatment* 
’Q7 Marital Status' 
’Q8 Children* 
*Q9 Major source of support* 
*Q10 Second major source of support* 
* Q11 Third major source of support* 
'Q12 I received the most support from church—spiritual * 
’Q12a I receive the second most support from church-spiritual1 
*Q13 Which clinician gave me the most support* 
* Q13a Which clinician gave me the second most support* 
’Q14 Formal peer services were arranged* 
*Q15 Formal group services were arranged* 
* Q16 Employment status* 
* 017 I have a place to live* 
* QI8 I have access to food—prepared meals' 
‘Q19 I have available transportation* 
* Q20 I need childcare assistance* 
1Q21 Health Insurance status* 
'Q22 Living arrangement* 






\ ’ Over 70 * / 
GENDER 
1 * Male’ 






5 ’Other */ 
DIAGNOS 
1 * Hodgkins * 
2 ’Follicular* 
3 ’Diffuse B-Cell* 
4 'Other NHL’/ 
STAGE 
1 ’Stage I* 
2 ’Stage II’ 
3 ’Stage III* 
4 ’Stage IV* 
5 ’Unknown */ 
TIME 
1 ’Less than 12 wks* 
2 * 12 - 26 wks * 
3 'More than 26 wks’/ 
MARITAL 
1 ’Married* 
2 ’Never married* 
3 ’Widowed* 
4 ’Divorced * 
5 ’Separated' 
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APPENDIX C (continued) 
'Domestic Partner*/ 
CHILD 
X ’None * 
2 ’Under lSyrs’ 
3 ’Over 18yrs'/ 
SUPORT1 
1 ’Family’ 




1 • Family* 
2 ’Extend Family* 
3 ’ Friends’ 
4 ’Other’/ 
SUPORT3 
1 * Family * 
2 'Extend Family’ 
3 * Friends * 
4 * other’/ 
SUPORT4 
1 ’None * 
2 ’Personal Prayer' 
3 ’church Attendance’ 
4 ’Visit with Clergy */ 
SUPORT5 
1 'Hone’ 
2 'Personal Prayer’ 
3 ’Church Attendance’ 
4 ’Visit with Clergy'/ 
SUPORT6 
1 ’None' 
! ’Nurse * 
3 ’Social Worker’ 
4 'Physician*/ 
SU PORT "7 
1 ’None’ 
2 ’Nurse’ 
3 ’Social VJorker ’ 
4 ’Physician’/ 
PEER 
1 * No ' 
2 ’Yes’/ 
GROUP 










1 * No ’ 
2 ’ Yes ’ / 
HEALS 
1 ■ No’ 
2 * Yea * / 
TRANS 
1 ’ No’ 
2 ’Yes’/ 
CHLDCA 





2 'Public Insurance' 
3 'Private Insurance' 
LTVING 
>Warning # 4492 in column 1. Text: LIVING 
>The {ADD) VALUE LABELS command included a symbol other than a value where 
>value {either numeric or string) was expected. For compatibility with 
>previous systems, a parenthesized value would have been acceptable. All 
>value labels up to the next slash will be ignored. 
1 ’Live alone' 





AGEGP.P GENDER ETHNIC DIAGNOS STAGE TIME MARITAL CHILD 
SUPORT1 SUP0RT2 SUP0RT3 SUPORT4 SUP0RT5 SUP0RT6 SUPORT7 
PEER GROUP EMPLOY PLACE MEALS TRANS CHLDCA INSURA LIVING TRIAL (0) . 
BEGIN DATA 
0013213211310023231242211321 
>Waming # 1102 
>An invalid numeric field has been found. The result has been set to the 
>system-missing value. 
Command line: 14 Current case: 1 Current splitfile group: 1 
>Field contents: '001' 




/VARIABLES AGEGRP GENDER ETHNIC DIAGNOS STAGE TIME MARITAL CHILD 
SUP0RT1 SUP0RT2 SUP0RT3 SUP0RT4 SUP0RT5 SUPORT6 SUP0RT7 
PEER GROUP EMPLOY PLACE MEALS TRANS CHLDCA INSURA LIVING TRIAL 
/STATISTICS=. 
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Notes. -Diagram of a modification of the Social Cognitive Theory with social support elements. 
-Cognitive, environmental, and behavioral factors influence patient health-seeking. 
-Cognitive, environmental, and behavioral factors are manifested by three types of 
social support: Instrumental, Informational, and Emotional Support 
-Positive outcome: Available support enhances the patient’s ability to seek 
medical treatment. 
-Negative outcome: Limited support reduces the patient’s ability to seek 
medical treatment. 
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Conceptual Model: The Influence of Social Support on Initial Treatment Delay in 
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